| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | GTPase activator activity | RGPD4 ARHGAP32 RANBP2 STARD8 RGPD8 TAGAP RGPD1 RABGAP1 TBC1D8B TIAM2 RGPD3 ERRFI1 ARHGAP29 RGPD5 | 5.82e-08 | 279 | 160 | 14 | GO:0005096 |
| GeneOntologyMolecularFunction | SUMO ligase activity | 4.36e-07 | 20 | 160 | 5 | GO:0061665 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | RGPD4 ARHGAP32 RANBP2 STARD8 RGPD8 RASGRF1 TAGAP RGPD1 MCF2 RABGAP1 TBC1D8B TIAM2 RGPD3 ERRFI1 ARHGAP29 SH3BP5 RGPD5 | 7.04e-07 | 507 | 160 | 17 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | RGPD4 ARHGAP32 RANBP2 STARD8 RGPD8 RASGRF1 TAGAP RGPD1 MCF2 RABGAP1 TBC1D8B TIAM2 RGPD3 ERRFI1 ARHGAP29 SH3BP5 RGPD5 | 7.04e-07 | 507 | 160 | 17 | GO:0030695 |
| GeneOntologyMolecularFunction | peptidyl-prolyl cis-trans isomerase activity | 2.86e-06 | 50 | 160 | 6 | GO:0003755 | |
| GeneOntologyMolecularFunction | cis-trans isomerase activity | 4.05e-06 | 53 | 160 | 6 | GO:0016859 | |
| GeneOntologyMolecularFunction | H3K27me3 modified histone binding | 4.99e-06 | 5 | 160 | 3 | GO:0061628 | |
| GeneOntologyMolecularFunction | enzyme activator activity | RGPD4 NRG1 ARHGAP32 RANBP2 STARD8 RGPD8 TAGAP RGPD1 RICTOR RABGAP1 TBC1D8B TIAM2 RGPD3 ERRFI1 ARHGAP29 NRG3 MAPK9 RGPD5 | 5.57e-06 | 656 | 160 | 18 | GO:0008047 |
| GeneOntologyMolecularFunction | SUMO transferase activity | 9.57e-06 | 36 | 160 | 5 | GO:0019789 | |
| GeneOntologyMolecularFunction | small GTPase binding | RGPD4 RANBP2 RGPD8 RASGRF1 DVL1 RGPD1 RABGAP1 SYTL5 RGPD3 ERRFI1 RAB11FIP3 | 5.78e-05 | 321 | 160 | 11 | GO:0031267 |
| GeneOntologyMolecularFunction | GTPase binding | RGPD4 RANBP2 RGPD8 RASGRF1 DVL1 RGPD1 RABGAP1 SYTL5 RGPD3 ERRFI1 RAB11FIP3 | 1.59e-04 | 360 | 160 | 11 | GO:0051020 |
| GeneOntologyMolecularFunction | JUN kinase activity | 1.90e-04 | 3 | 160 | 2 | GO:0004705 | |
| GeneOntologyMolecularFunction | telomeric repeat-containing RNA binding | 1.90e-04 | 3 | 160 | 2 | GO:0061752 | |
| GeneOntologyMolecularFunction | calcium-dependent cysteine-type endopeptidase activity | 3.16e-04 | 17 | 160 | 3 | GO:0004198 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | TPR ANK3 CAPN2 APC2 LMTK2 RABGAP1 DBN1 SHANK3 CEP350 SETD2 PTPRC SSH1 CCSER2 KIRREL1 DLEC1 PLEKHH2 UTRN TOR1AIP1 PALLD EPB41L1 | 5.12e-04 | 1099 | 160 | 20 | GO:0008092 |
| GeneOntologyMolecularFunction | RNA strand annealing activity | 6.28e-04 | 5 | 160 | 2 | GO:0033592 | |
| GeneOntologyMolecularFunction | methylated histone binding | 6.41e-04 | 86 | 160 | 5 | GO:0035064 | |
| GeneOntologyMolecularFunction | methylation-dependent protein binding | 7.12e-04 | 88 | 160 | 5 | GO:0140034 | |
| GeneOntologyMolecularFunction | enzyme regulator activity | RGPD4 NRG1 ARHGAP32 RANBP2 STARD8 RGPD8 RASGRF1 TAGAP PPP1R3B RGPD1 LMTK2 MCF2 RICTOR RABGAP1 TBC1D8B TIAM2 RGPD3 ERRFI1 ARHGAP29 NRG3 MAPK9 SH3BP5 RGPD5 | 9.45e-04 | 1418 | 160 | 23 | GO:0030234 |
| GeneOntologyMolecularFunction | structural constituent of nuclear pore | 1.02e-03 | 25 | 160 | 3 | GO:0017056 | |
| GeneOntologyMolecularFunction | protein kinase A binding | 1.20e-03 | 58 | 160 | 4 | GO:0051018 | |
| GeneOntologyMolecularFunction | modification-dependent protein binding | 1.39e-03 | 206 | 160 | 7 | GO:0140030 | |
| GeneOntologyMolecularFunction | lysine-acetylated histone binding | 1.75e-03 | 30 | 160 | 3 | GO:0070577 | |
| GeneOntologyMolecularFunction | acetylation-dependent protein binding | 1.92e-03 | 31 | 160 | 3 | GO:0140033 | |
| GeneOntologyMolecularFunction | RNA polymerase I general transcription initiation factor activity | 2.21e-03 | 9 | 160 | 2 | GO:0001181 | |
| GeneOntologyMolecularFunction | histone modifying activity | 2.52e-03 | 229 | 160 | 7 | GO:0140993 | |
| GeneOntologyBiologicalProcess | positive regulation of glucokinase activity | 3.04e-09 | 9 | 158 | 5 | GO:0033133 | |
| GeneOntologyBiologicalProcess | positive regulation of hexokinase activity | 6.05e-09 | 10 | 158 | 5 | GO:1903301 | |
| GeneOntologyBiologicalProcess | NLS-bearing protein import into nucleus | 6.52e-09 | 20 | 158 | 6 | GO:0006607 | |
| GeneOntologyBiologicalProcess | mRNA transport | RGPD4 TPR RANBP2 RGPD8 RGPD1 HNRNPA1L2 HNRNPA1 SETD2 RGPD3 NUP133 NUP160 | 1.57e-08 | 145 | 158 | 11 | GO:0051028 |
| GeneOntologyBiologicalProcess | regulation of glucokinase activity | 3.03e-08 | 13 | 158 | 5 | GO:0033131 | |
| GeneOntologyBiologicalProcess | regulation of hexokinase activity | 4.69e-08 | 14 | 158 | 5 | GO:1903299 | |
| GeneOntologyBiologicalProcess | RNA transport | RGPD4 TPR RANBP2 RGPD8 RGPD1 HNRNPA1L2 HNRNPA1 SETD2 RGPD3 NUP133 NUP160 | 1.09e-07 | 175 | 158 | 11 | GO:0050658 |
| GeneOntologyBiologicalProcess | nucleic acid transport | RGPD4 TPR RANBP2 RGPD8 RGPD1 HNRNPA1L2 HNRNPA1 SETD2 RGPD3 NUP133 NUP160 | 1.09e-07 | 175 | 158 | 11 | GO:0050657 |
| GeneOntologyBiologicalProcess | establishment of RNA localization | RGPD4 TPR RANBP2 RGPD8 RGPD1 HNRNPA1L2 HNRNPA1 SETD2 RGPD3 NUP133 NUP160 | 1.30e-07 | 178 | 158 | 11 | GO:0051236 |
| GeneOntologyBiologicalProcess | protein peptidyl-prolyl isomerization | 4.14e-07 | 38 | 158 | 6 | GO:0000413 | |
| GeneOntologyBiologicalProcess | RNA localization | RGPD4 TPR RANBP2 RGPD8 RGPD1 HNRNPA1L2 HNRNPA1 SETD2 RGPD3 NUP133 NUP160 | 9.44e-07 | 217 | 158 | 11 | GO:0006403 |
| GeneOntologyBiologicalProcess | nuclear export | RGPD4 TPR RANBP2 RGPD8 RGPD1 HNRNPA1 SETD2 RGPD3 NUP133 NUP160 | 1.68e-06 | 185 | 158 | 10 | GO:0051168 |
| GeneOntologyBiologicalProcess | peptidyl-proline modification | 3.50e-06 | 54 | 158 | 6 | GO:0018208 | |
| GeneOntologyBiologicalProcess | nucleobase-containing compound transport | RGPD4 TPR RANBP2 RGPD8 RGPD1 HNRNPA1L2 HNRNPA1 SETD2 RGPD3 NUP133 NUP160 | 3.59e-06 | 249 | 158 | 11 | GO:0015931 |
| GeneOntologyBiologicalProcess | protein localization to nucleus | RGPD4 TPR RANBP2 RGPD8 DVL1 RGPD1 NUAK2 KAT7 LMNB1 RGPD3 NUP133 TOR1AIP1 RGPD5 | 4.53e-06 | 362 | 158 | 13 | GO:0034504 |
| GeneOntologyBiologicalProcess | positive regulation of cellular component organization | TPR RALB NRG1 ARHGAP32 RIPOR2 AHI1 TRHR ATRX CAPN2 DVL1 RICTOR DBN1 HNRNPA1 SHANK3 TIAM2 RETREG3 CRACD PTPRC SSH1 PTPRZ1 ATF7IP KIRREL1 MAPK9 DYNC1H1 CREB3L2 RAB11FIP3 | 1.49e-05 | 1366 | 158 | 26 | GO:0051130 |
| GeneOntologyBiologicalProcess | neuron projection development | EPHB6 NRG1 ARHGAP32 RIPOR2 AHI1 ANK3 RASGRF1 DVL1 LMTK2 LAMB1 MCF2 DBN1 PIP5K1C OMG SHANK3 TIAM2 RETREG3 DACT1 ARID1B PTPRZ1 PRMT3 MAPK9 SDK1 PALLD CREB3L2 | 1.54e-05 | 1285 | 158 | 25 | GO:0031175 |
| GeneOntologyBiologicalProcess | import into nucleus | 2.54e-05 | 201 | 158 | 9 | GO:0051170 | |
| GeneOntologyBiologicalProcess | neuron development | EPHB6 NRG1 ARHGAP32 RIPOR2 AHI1 ANK3 RASGRF1 DVL1 LMTK2 LAMB1 MCF2 DBN1 PIP5K1C OMG SHANK3 TIAM2 RETREG3 DACT1 ARID1B LMX1B PTPRZ1 PRMT3 MAPK9 SDK1 PALLD CREB3L2 | 4.79e-05 | 1463 | 158 | 26 | GO:0048666 |
| GeneOntologyBiologicalProcess | chemorepulsion involved in interneuron migration from the subpallium to the cortex | 5.83e-05 | 2 | 158 | 2 | GO:0021842 | |
| GeneOntologyBiologicalProcess | directional guidance of interneurons involved in migration from the subpallium to the cortex | 5.83e-05 | 2 | 158 | 2 | GO:0021840 | |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | EPHB6 ARHGAP32 RIPOR2 ANK3 DVL1 LMTK2 LAMB1 MCF2 DBN1 PIP5K1C OMG SHANK3 TIAM2 DACT1 PTPRZ1 PRMT3 PALLD | 6.29e-05 | 748 | 158 | 17 | GO:0048667 |
| GeneOntologyBiologicalProcess | synapse organization | NRG1 ANK3 DVL1 DBN1 SHANK3 C1QL2 DACT1 DLGAP3 SSH1 LMX1B TLR2 PRMT3 NRG3 CDH6 SDK1 PALLD | 7.60e-05 | 685 | 158 | 16 | GO:0050808 |
| GeneOntologyBiologicalProcess | cell morphogenesis | EPHB6 NRG1 ARHGAP32 RIPOR2 ANK3 DVL1 LMTK2 LAMB1 MCF2 DBN1 PIP5K1C OMG SHANK3 TIAM2 DACT1 HEG1 SSH1 PTPRZ1 PRMT3 CDH6 PALLD BRWD1 | 1.17e-04 | 1194 | 158 | 22 | GO:0000902 |
| GeneOntologyBiologicalProcess | protein import into nucleus | 1.33e-04 | 195 | 158 | 8 | GO:0006606 | |
| GeneOntologyBiologicalProcess | regulation of cytoskeleton organization | TPR RIPOR2 PDGFRA CAPN2 APC2 RICTOR DBN1 SHANK3 CRACD SSH1 TLR2 KIRREL1 PLEKHH2 DYNC1H1 | 1.52e-04 | 579 | 158 | 14 | GO:0051493 |
| GeneOntologyBiologicalProcess | nuclear transport | RGPD4 TPR RANBP2 RGPD8 RGPD1 HNRNPA1 SETD2 RGPD3 NUP133 NUP160 RGPD5 | 1.65e-04 | 378 | 158 | 11 | GO:0051169 |
| GeneOntologyBiologicalProcess | nucleocytoplasmic transport | RGPD4 TPR RANBP2 RGPD8 RGPD1 HNRNPA1 SETD2 RGPD3 NUP133 NUP160 RGPD5 | 1.65e-04 | 378 | 158 | 11 | GO:0006913 |
| GeneOntologyBiologicalProcess | cell junction organization | NRG1 ANK3 DVL1 DBN1 PIP5K1C SHANK3 C1QL2 DACT1 DLGAP3 HEG1 SSH1 LMX1B TLR2 KIRREL1 PRMT3 NRG3 CDH6 SDK1 PALLD | 1.72e-04 | 974 | 158 | 19 | GO:0034330 |
| GeneOntologyBiologicalProcess | chromatin remodeling | MIER2 TPR ATRX PHF19 RAD54L2 TRIP12 KAT7 SETD2 ARID1B LMNB1 ATF7IP CHD5 ATAD2B PRMT3 TAF1 TAF1L | 1.87e-04 | 741 | 158 | 16 | GO:0006338 |
| GeneOntologyBiologicalProcess | regulation of gluconeogenesis | 2.14e-04 | 71 | 158 | 5 | GO:0006111 | |
| GeneOntologyBiologicalProcess | positive regulation of molecular function | RGPD4 EPHB6 RALB NRG1 RANBP2 RIPOR2 RGPD8 ANK3 RASGRF1 PDGFRA APC2 RGPD1 TBC1D8B SHANK3 TIAM2 DACT1 RTKN2 PTPRC RGPD3 TLR2 ARHGAP29 TAF1 TOR1AIP1 ZC3HAV1 | 2.31e-04 | 1430 | 158 | 24 | GO:0044093 |
| GeneOntologyBiologicalProcess | regulation of organelle organization | TPR RALB RIPOR2 ATRX PDGFRA VPS13C CAPN2 APC2 RICTOR RABGAP1 DBN1 HNRNPA1 SHANK3 CRACD ARID1B SSH1 ATF7IP TLR2 KIRREL1 PLEKHH2 MAPK9 DYNC1H1 RAB11FIP3 | 2.34e-04 | 1342 | 158 | 23 | GO:0033043 |
| GeneOntologyBiologicalProcess | regulation of small GTPase mediated signal transduction | NRG1 ARHGAP32 RIPOR2 STARD8 RASGRF1 TAGAP MCF2 TIAM2 HEG1 ARHGAP29 | 2.55e-04 | 333 | 158 | 10 | GO:0051056 |
| GeneOntologyBiologicalProcess | protein localization to organelle | RGPD4 TPR RANBP2 AHI1 RGPD8 ATRX VPS13C DVL1 RGPD1 NUAK2 CEP350 KAT7 C1QL2 SETD2 LMNB1 RGPD3 NUP133 TOR1AIP1 RGPD5 RAB11FIP3 | 2.61e-04 | 1091 | 158 | 20 | GO:0033365 |
| GeneOntologyBiologicalProcess | positive regulation of excitatory postsynaptic potential | 3.24e-04 | 43 | 158 | 4 | GO:2000463 | |
| GeneOntologyBiologicalProcess | positive regulation of action potential | 3.31e-04 | 18 | 158 | 3 | GO:0045760 | |
| GeneOntologyBiologicalProcess | axonogenesis | EPHB6 ARHGAP32 ANK3 DVL1 LMTK2 LAMB1 MCF2 DBN1 PIP5K1C OMG TIAM2 PTPRZ1 PALLD | 4.29e-04 | 566 | 158 | 13 | GO:0007409 |
| GeneOntologyBiologicalProcess | axon development | EPHB6 NRG1 ARHGAP32 ANK3 DVL1 LMTK2 LAMB1 MCF2 DBN1 PIP5K1C OMG TIAM2 PTPRZ1 PALLD | 4.34e-04 | 642 | 158 | 14 | GO:0061564 |
| GeneOntologyBiologicalProcess | regulation of actin polymerization or depolymerization | 4.37e-04 | 177 | 158 | 7 | GO:0008064 | |
| GeneOntologyBiologicalProcess | intracellular transport | RGPD4 TPR RANBP2 RGPD8 ANK3 VPS13C RGPD1 LMTK2 TACC2 DBN1 HNRNPA1 SETD2 LMNB1 LMX1B SYTL5 RGPD3 NUP133 LRBA GRAMD1C NUP160 DYNC1H1 CREB3L2 RGPD5 RAB11FIP3 | 4.46e-04 | 1496 | 158 | 24 | GO:0046907 |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | EPHB6 ARHGAP32 ANK3 DVL1 LMTK2 LAMB1 MCF2 DBN1 PIP5K1C OMG SHANK3 TIAM2 DACT1 PTPRZ1 PRMT3 PALLD | 4.51e-04 | 802 | 158 | 16 | GO:0048812 |
| GeneOntologyBiologicalProcess | regulation of actin filament length | 4.84e-04 | 180 | 158 | 7 | GO:0030832 | |
| GeneOntologyBiologicalProcess | peptidyl-amino acid modification | RGPD4 NRG1 RANBP2 RGPD8 PDGFRA RGPD1 LMTK2 RICTOR KAT7 SETD2 AATK PTPRC PTPRZ1 RGPD3 ERRFI1 PRMT3 NKTR TAF1 | 5.03e-04 | 976 | 158 | 18 | GO:0018193 |
| GeneOntologyBiologicalProcess | chromatin organization | MIER2 TPR ATRX PHF19 RAD54L2 TRIP12 KAT7 SETD2 ARID1B SAFB LMNB1 ATF7IP CHD5 ATAD2B PRMT3 TAF1 TAF1L | 5.27e-04 | 896 | 158 | 17 | GO:0006325 |
| GeneOntologyBiologicalProcess | regulation of carbohydrate biosynthetic process | 5.44e-04 | 132 | 158 | 6 | GO:0043255 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | EPHB6 ARHGAP32 ANK3 DVL1 LMTK2 LAMB1 MCF2 DBN1 PIP5K1C OMG SHANK3 TIAM2 DACT1 PTPRZ1 PRMT3 PALLD | 5.65e-04 | 819 | 158 | 16 | GO:0120039 |
| GeneOntologyBiologicalProcess | nucleotide-excision repair | 5.81e-04 | 88 | 158 | 5 | GO:0006289 | |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | EPHB6 ARHGAP32 ANK3 DVL1 LMTK2 LAMB1 MCF2 DBN1 PIP5K1C OMG SHANK3 TIAM2 DACT1 PTPRZ1 PRMT3 PALLD | 6.20e-04 | 826 | 158 | 16 | GO:0048858 |
| GeneOntologyBiologicalProcess | negative regulation of cytoskeleton organization | 7.54e-04 | 194 | 158 | 7 | GO:0051494 | |
| GeneOntologyBiologicalProcess | dendritic spine development | 7.69e-04 | 141 | 158 | 6 | GO:0060996 | |
| GeneOntologyBiologicalProcess | regulation of plasma membrane bounded cell projection organization | NRG1 ARHGAP32 RIPOR2 AHI1 DVL1 MCF2 RABGAP1 DBN1 OMG SHANK3 TIAM2 RETREG3 PTPRZ1 PLD1 CREB3L2 RAB11FIP3 | 7.99e-04 | 846 | 158 | 16 | GO:0120035 |
| GeneOntologyBiologicalProcess | negative regulation of supramolecular fiber organization | 8.25e-04 | 197 | 158 | 7 | GO:1902904 | |
| GeneOntologyBiologicalProcess | RNA export from nucleus | 8.64e-04 | 96 | 158 | 5 | GO:0006405 | |
| GeneOntologyCellularComponent | cytoplasmic periphery of the nuclear pore complex | 1.40e-09 | 8 | 161 | 5 | GO:1990723 | |
| GeneOntologyCellularComponent | nuclear pore nuclear basket | 3.27e-09 | 18 | 161 | 6 | GO:0044615 | |
| GeneOntologyCellularComponent | nuclear pore cytoplasmic filaments | 6.22e-09 | 10 | 161 | 5 | GO:0044614 | |
| GeneOntologyCellularComponent | nuclear inclusion body | 6.74e-09 | 20 | 161 | 6 | GO:0042405 | |
| GeneOntologyCellularComponent | annulate lamellae | 4.82e-08 | 14 | 161 | 5 | GO:0005642 | |
| GeneOntologyCellularComponent | nuclear pore | 8.69e-08 | 101 | 161 | 9 | GO:0005643 | |
| GeneOntologyCellularComponent | SUMO ligase complex | 4.69e-07 | 21 | 161 | 5 | GO:0106068 | |
| GeneOntologyCellularComponent | nuclear membrane | RGPD4 TPR RANBP2 BRIP1 RGPD8 RGPD1 TNRC18 LMNB1 RGPD3 OSBPL7 NUP133 TOR1AIP1 | 1.75e-05 | 349 | 161 | 12 | GO:0031965 |
| GeneOntologyCellularComponent | nuclear envelope | RGPD4 TPR RANBP2 BRIP1 RGPD8 RGPD1 TNRC18 LMNB1 RGPD3 OSBPL7 NUP133 TOR1AIP1 NUP160 DYNC1H1 RGPD5 | 2.96e-05 | 560 | 161 | 15 | GO:0005635 |
| GeneOntologyCellularComponent | filopodium | 4.74e-05 | 123 | 161 | 7 | GO:0030175 | |
| GeneOntologyCellularComponent | inclusion body | 6.94e-05 | 90 | 161 | 6 | GO:0016234 | |
| GeneOntologyCellularComponent | asymmetric synapse | NRG1 ARHGAP32 ANK3 DVL1 DBN1 PIP5K1C SHANK3 C1QL2 DLGAP3 PTPRZ1 MAPK10 EPB41L1 | 3.36e-04 | 477 | 161 | 12 | GO:0032279 |
| GeneOntologyCellularComponent | lamellipodium | 4.22e-04 | 230 | 161 | 8 | GO:0030027 | |
| GeneOntologyCellularComponent | growth cone | 6.40e-04 | 245 | 161 | 8 | GO:0030426 | |
| GeneOntologyCellularComponent | neuron to neuron synapse | NRG1 ARHGAP32 ANK3 DVL1 DBN1 PIP5K1C SHANK3 C1QL2 DLGAP3 PTPRZ1 MAPK10 EPB41L1 | 7.58e-04 | 523 | 161 | 12 | GO:0098984 |
| GeneOntologyCellularComponent | postsynaptic density | NRG1 ARHGAP32 ANK3 DVL1 DBN1 PIP5K1C SHANK3 DLGAP3 PTPRZ1 MAPK10 EPB41L1 | 7.66e-04 | 451 | 161 | 11 | GO:0014069 |
| GeneOntologyCellularComponent | site of polarized growth | 7.89e-04 | 253 | 161 | 8 | GO:0030427 | |
| GeneOntologyCellularComponent | nucleoplasmic periphery of the nuclear pore complex | 8.67e-04 | 6 | 161 | 2 | GO:1990826 | |
| GeneOntologyCellularComponent | perinuclear endoplasmic reticulum | 1.41e-03 | 29 | 161 | 3 | GO:0097038 | |
| GeneOntologyCellularComponent | actin-based cell projection | 1.44e-03 | 278 | 161 | 8 | GO:0098858 | |
| GeneOntologyCellularComponent | glycogen granule | 1.60e-03 | 8 | 161 | 2 | GO:0042587 | |
| GeneOntologyCellularComponent | cell leading edge | PDE4A RIPOR2 APC2 DBN1 PIP5K1C TIAM2 SSH1 PTPRZ1 PLD1 PLEKHH2 PALLD | 1.75e-03 | 500 | 161 | 11 | GO:0031252 |
| GeneOntologyCellularComponent | postsynaptic specialization | NRG1 ARHGAP32 ANK3 DVL1 DBN1 PIP5K1C SHANK3 DLGAP3 PTPRZ1 MAPK10 EPB41L1 | 1.83e-03 | 503 | 161 | 11 | GO:0099572 |
| GeneOntologyCellularComponent | nuclear protein-containing complex | RGPD4 TPR RANBP2 BRIP1 RGPD8 PHF19 RGPD1 E2F7 GON4L HNRNPA1L2 TSSC4 HNRNPA1 KAT7 ARID1B CHD5 RGPD3 NUP133 TAF1 TAF1L NUP160 RGPD5 | 2.09e-03 | 1377 | 161 | 21 | GO:0140513 |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | RGPD4 RANBP2 PDE4A RGPD8 CAPN2 APC2 RGPD1 LMTK2 LAMB1 DBN1 AATK RGPD3 OSBPL7 KIRREL1 PLD1 CREB3L2 | 2.35e-03 | 934 | 161 | 16 | GO:0048471 |
| GeneOntologyCellularComponent | perineuronal net | 2.55e-03 | 10 | 161 | 2 | GO:0072534 | |
| GeneOntologyCellularComponent | nuclear pore outer ring | 2.55e-03 | 10 | 161 | 2 | GO:0031080 | |
| GeneOntologyCellularComponent | basement membrane | 2.56e-03 | 122 | 161 | 5 | GO:0005604 | |
| GeneOntologyCellularComponent | somatodendritic compartment | EPHB6 ARHGAP32 ANK3 RASGRF1 CAPN2 DVL1 LMTK2 DBN1 SHANK3 TIAM2 DLGAP3 CLCN2 PTPRZ1 ACAN KIRREL1 MAPK9 MAPK10 PALLD DYNC1H1 | 2.93e-03 | 1228 | 161 | 19 | GO:0036477 |
| GeneOntologyCellularComponent | perisynaptic extracellular matrix | 3.10e-03 | 11 | 161 | 2 | GO:0098966 | |
| MousePheno | elevated level of mitotic sister chromatid exchange | 2.80e-07 | 16 | 132 | 5 | MP:0003701 | |
| MousePheno | decreased tumor latency | 3.12e-07 | 30 | 132 | 6 | MP:0010308 | |
| MousePheno | abnormal tumor latency | 6.85e-07 | 34 | 132 | 6 | MP:0010307 | |
| MousePheno | abnormal morula morphology | 3.90e-06 | 26 | 132 | 5 | MP:0012058 | |
| MousePheno | failure of blastocyst formation | 9.71e-06 | 31 | 132 | 5 | MP:0012129 | |
| MousePheno | increased malignant tumor incidence | RGPD4 RANBP2 BRIP1 RGPD8 RGPD1 GON4L PTPRZ1 RGPD3 TLR2 ERRFI1 DCLRE1A | 1.51e-05 | 237 | 132 | 11 | MP:0002018 |
| MousePheno | abnormal blastocyst formation | 3.10e-05 | 39 | 132 | 5 | MP:0012128 | |
| MousePheno | abnormal CNS synaptic transmission | NRG1 ARHGAP32 HIVEP1 ATRX RASGRF1 CEP85L DVL1 RABGAP1 DBN1 PIP5K1C SHANK3 FAM135B RETREG3 DACT1 NEK1 DLGAP3 SETD2 ARID1B PTPRZ1 NKAPD1 CRYBG1 NRG3 MAPK9 | 4.52e-05 | 985 | 132 | 23 | MP:0002206 |
| MousePheno | increased sarcoma incidence | 5.00e-05 | 102 | 132 | 7 | MP:0002032 | |
| MousePheno | abnormal synaptic transmission | NRG1 ARHGAP32 HIVEP1 ATRX RASGRF1 CEP85L DVL1 RABGAP1 DBN1 PIP5K1C SHANK3 FAM135B RETREG3 DACT1 NEK1 DLGAP3 SETD2 ARID1B PTPRZ1 NKAPD1 CRYBG1 NRG3 MAPK9 UTRN | 5.72e-05 | 1070 | 132 | 24 | MP:0003635 |
| MousePheno | abnormal cell nucleus morphology | 6.16e-05 | 184 | 132 | 9 | MP:0003111 | |
| MousePheno | abnormal synaptic physiology | NRG1 ARHGAP32 HIVEP1 ATRX RASGRF1 CEP85L DVL1 RABGAP1 DBN1 PIP5K1C SHANK3 FAM135B RETREG3 DACT1 NEK1 DLGAP3 SETD2 ARID1B PTPRZ1 NKAPD1 CRYBG1 NRG3 MAPK9 UTRN | 6.25e-05 | 1076 | 132 | 24 | MP:0021009 |
| MousePheno | tongue muscle hypoplasia | 8.85e-05 | 2 | 132 | 2 | MP:0030421 | |
| MousePheno | increased carcinoma incidence | 1.04e-04 | 197 | 132 | 9 | MP:0002038 | |
| MousePheno | abnormal prepulse inhibition | NRG1 HIVEP1 CEP85L DVL1 RABGAP1 DBN1 SHANK3 FAM135B RETREG3 NEK1 SETD2 ARID1B NKAPD1 CRYBG1 NRG3 | 1.82e-04 | 542 | 132 | 15 | MP:0003088 |
| MousePheno | abnormal chromosome morphology | 1.90e-04 | 126 | 132 | 7 | MP:0003702 | |
| MousePheno | increased classified tumor incidence | RGPD4 RANBP2 BRIP1 RGPD8 RGPD1 GON4L NUAK2 PTPRZ1 RGPD3 TLR2 ERRFI1 DCLRE1A | 2.60e-04 | 381 | 132 | 12 | MP:0010273 |
| MousePheno | abnormal habituation to a novel odor | 2.64e-04 | 3 | 132 | 2 | MP:0011622 | |
| MousePheno | aneuploidy | 2.71e-04 | 61 | 132 | 5 | MP:0004024 | |
| MousePheno | abnormal classified tumor incidence | RGPD4 RANBP2 BRIP1 RGPD8 RGPD1 GON4L NUAK2 PTPRZ1 RGPD3 TLR2 ERRFI1 DCLRE1A | 2.80e-04 | 384 | 132 | 12 | MP:0020188 |
| MousePheno | abnormal intercostal muscle morphology | 3.45e-04 | 15 | 132 | 3 | MP:0002280 | |
| MousePheno | enlarged epididymis | 3.46e-04 | 99 | 132 | 6 | MP:0004931 | |
| MousePheno | increased organ/body region tumor incidence | RGPD4 RANBP2 BRIP1 RGPD8 RGPD1 GON4L NUAK2 PTPRZ1 RGPD3 TLR2 ERRFI1 DCLRE1A | 3.61e-04 | 395 | 132 | 12 | MP:0010274 |
| MousePheno | abnormal organ/body region tumor incidence | RGPD4 RANBP2 BRIP1 RGPD8 RGPD1 GON4L NUAK2 PTPRZ1 RGPD3 TLR2 ERRFI1 DCLRE1A | 4.14e-04 | 401 | 132 | 12 | MP:0013152 |
| MousePheno | decreased prepulse inhibition | HIVEP1 CEP85L DVL1 RABGAP1 SHANK3 FAM135B RETREG3 NEK1 SETD2 ARID1B NKAPD1 CRYBG1 NRG3 | 4.45e-04 | 464 | 132 | 13 | MP:0009142 |
| MousePheno | increased hepatocellular carcinoma incidence | 5.15e-04 | 70 | 132 | 5 | MP:0003331 | |
| MousePheno | increased respiratory system tumor incidence | 5.24e-04 | 107 | 132 | 6 | MP:0010298 | |
| MousePheno | increased lung tumor incidence | 5.24e-04 | 107 | 132 | 6 | MP:0008014 | |
| MousePheno | fetal bleb | 5.24e-04 | 4 | 132 | 2 | MP:0008856 | |
| MousePheno | abnormal huddling behavior | 5.24e-04 | 4 | 132 | 2 | MP:0021117 | |
| Domain | Ran_BP1 | 3.07e-10 | 12 | 159 | 6 | PF00638 | |
| Domain | RANBD1 | 3.07e-10 | 12 | 159 | 6 | PS50196 | |
| Domain | RanBD | 5.66e-10 | 13 | 159 | 6 | SM00160 | |
| Domain | Ran_bind_dom | 5.66e-10 | 13 | 159 | 6 | IPR000156 | |
| Domain | Grip | 1.86e-08 | 11 | 159 | 5 | SM00755 | |
| Domain | GRIP | 1.86e-08 | 11 | 159 | 5 | PF01465 | |
| Domain | GRIP_dom | 3.17e-08 | 12 | 159 | 5 | IPR000237 | |
| Domain | GRIP | 3.17e-08 | 12 | 159 | 5 | PS50913 | |
| Domain | PH_dom-like | RGPD4 RANBP2 RGPD8 RASGRF1 RGPD1 MCF2 RABGAP1 TIAM2 PLEKHH1 RTKN2 RGPD3 OSBPL7 PLD1 LRBA PLEKHH2 EPB41L1 RGPD5 | 1.41e-07 | 426 | 159 | 17 | IPR011993 |
| Domain | Rab_bind | 1.74e-07 | 7 | 159 | 4 | PF16704 | |
| Domain | GCC2_Rab_bind | 1.74e-07 | 7 | 159 | 4 | IPR032023 | |
| Domain | - | 1.02e-06 | 10 | 159 | 4 | 1.10.220.60 | |
| Domain | - | RGPD4 RANBP2 RGPD8 RASGRF1 RGPD1 MCF2 RABGAP1 TIAM2 PLEKHH1 RTKN2 RGPD3 OSBPL7 PLD1 PLEKHH2 EPB41L1 | 1.31e-06 | 391 | 159 | 15 | 2.30.29.30 |
| Domain | Bromodomain_CS | 6.53e-05 | 26 | 159 | 4 | IPR018359 | |
| Domain | TFIID_sub1_DUF3591 | 7.20e-05 | 2 | 159 | 2 | IPR022591 | |
| Domain | TBP-binding | 7.20e-05 | 2 | 159 | 2 | PF09247 | |
| Domain | DUF3591 | 7.20e-05 | 2 | 159 | 2 | PF12157 | |
| Domain | TAF_II_230-bd | 7.20e-05 | 2 | 159 | 2 | IPR009067 | |
| Domain | - | 7.20e-05 | 2 | 159 | 2 | 1.10.1100.10 | |
| Domain | DVL-1 | 7.20e-05 | 2 | 159 | 2 | IPR008340 | |
| Domain | TAF1_animal | 7.20e-05 | 2 | 159 | 2 | IPR011177 | |
| Domain | HnRNPA1 | 2.15e-04 | 3 | 159 | 2 | IPR021662 | |
| Domain | Neuregulin_C | 2.15e-04 | 3 | 159 | 2 | IPR002154 | |
| Domain | Neuregulin | 2.15e-04 | 3 | 159 | 2 | PF02158 | |
| Domain | HnRNPA1 | 2.15e-04 | 3 | 159 | 2 | PF11627 | |
| Domain | Ig_I-set | 2.27e-04 | 190 | 159 | 8 | IPR013098 | |
| Domain | I-set | 2.27e-04 | 190 | 159 | 8 | PF07679 | |
| Domain | Peptidase_C2 | 2.56e-04 | 15 | 159 | 3 | PF00648 | |
| Domain | CysPc | 2.56e-04 | 15 | 159 | 3 | SM00230 | |
| Domain | Peptidase_C2_calpain_cat | 2.56e-04 | 15 | 159 | 3 | IPR001300 | |
| Domain | CALPAIN_CAT | 2.56e-04 | 15 | 159 | 3 | PS50203 | |
| Domain | BROMODOMAIN_1 | 2.68e-04 | 37 | 159 | 4 | PS00633 | |
| Domain | Bromodomain | 2.98e-04 | 38 | 159 | 4 | PF00439 | |
| Domain | BROMODOMAIN_2 | 4.01e-04 | 41 | 159 | 4 | PS50014 | |
| Domain | Dishevelled | 4.27e-04 | 4 | 159 | 2 | PF02377 | |
| Domain | Dishevelled_fam | 4.27e-04 | 4 | 159 | 2 | IPR008339 | |
| Domain | Dishevelled_protein_dom | 4.27e-04 | 4 | 159 | 2 | IPR003351 | |
| Domain | Bromodomain | 4.40e-04 | 42 | 159 | 4 | IPR001487 | |
| Domain | BROMO | 4.40e-04 | 42 | 159 | 4 | SM00297 | |
| Domain | - | 4.40e-04 | 42 | 159 | 4 | 1.20.920.10 | |
| Domain | MAPK_JNK | 7.08e-04 | 5 | 159 | 2 | IPR008351 | |
| Domain | PH | 7.84e-04 | 229 | 159 | 8 | PF00169 | |
| Domain | - | 7.95e-04 | 49 | 159 | 4 | 1.20.80.10 | |
| Domain | SANT | 8.59e-04 | 50 | 159 | 4 | SM00717 | |
| Domain | FERM/acyl-CoA-bd_prot_3-hlx | 8.59e-04 | 50 | 159 | 4 | IPR014352 | |
| Domain | IGc2 | 9.27e-04 | 235 | 159 | 8 | SM00408 | |
| Domain | Ig_sub2 | 9.27e-04 | 235 | 159 | 8 | IPR003598 | |
| Domain | SANT/Myb | 9.96e-04 | 52 | 159 | 4 | IPR001005 | |
| Domain | Myb-like_dom | 1.06e-03 | 6 | 159 | 2 | IPR017877 | |
| Domain | DIX | 1.47e-03 | 7 | 159 | 2 | PF00778 | |
| Domain | DIX | 1.47e-03 | 7 | 159 | 2 | IPR001158 | |
| Domain | DIX | 1.47e-03 | 7 | 159 | 2 | PS50841 | |
| Domain | DAX | 1.47e-03 | 7 | 159 | 2 | SM00021 | |
| Domain | TPR-contain_dom | 1.81e-03 | 150 | 159 | 6 | IPR013026 | |
| Domain | RhoGAP | 1.92e-03 | 62 | 159 | 4 | SM00324 | |
| Domain | Calx_beta | 1.95e-03 | 8 | 159 | 2 | SM00237 | |
| Domain | RhoGAP | 2.04e-03 | 63 | 159 | 4 | PF00620 | |
| Domain | RhoGAP_dom | 2.16e-03 | 64 | 159 | 4 | IPR000198 | |
| Domain | RHOGAP | 2.16e-03 | 64 | 159 | 4 | PS50238 | |
| Domain | - | 2.16e-03 | 64 | 159 | 4 | 1.10.555.10 | |
| Domain | Calx_beta | 2.49e-03 | 9 | 159 | 2 | IPR003644 | |
| Domain | MYTH4 | 2.49e-03 | 9 | 159 | 2 | PS51016 | |
| Domain | MyTH4 | 2.49e-03 | 9 | 159 | 2 | SM00139 | |
| Domain | MyTH4_dom | 2.49e-03 | 9 | 159 | 2 | IPR000857 | |
| Domain | MyTH4 | 2.49e-03 | 9 | 159 | 2 | PF00784 | |
| Domain | Calx-beta | 2.49e-03 | 9 | 159 | 2 | PF03160 | |
| Domain | SNF2_N | 2.51e-03 | 32 | 159 | 3 | IPR000330 | |
| Domain | SNF2_N | 2.51e-03 | 32 | 159 | 3 | PF00176 | |
| Domain | PH | 2.67e-03 | 278 | 159 | 8 | SM00233 | |
| Domain | PH_DOMAIN | 2.73e-03 | 279 | 159 | 8 | PS50003 | |
| Domain | PH_domain | 2.79e-03 | 280 | 159 | 8 | IPR001849 | |
| Domain | TPR_REGION | 2.92e-03 | 165 | 159 | 6 | PS50293 | |
| Domain | TPR | 2.92e-03 | 165 | 159 | 6 | PS50005 | |
| Domain | GDS_CDC24_CS | 4.42e-03 | 39 | 159 | 3 | IPR001331 | |
| Domain | - | EPHB6 NRG1 MXRA5 PDGFRA LINGO3 MFAP3 PTPRC PTPRZ1 ATF7IP KIRREL1 FNDC8 SDK1 PALLD | 4.45e-03 | 663 | 159 | 13 | 2.60.40.10 |
| Domain | calpain_III | 4.49e-03 | 12 | 159 | 2 | SM00720 | |
| Domain | C2_III | 4.49e-03 | 12 | 159 | 2 | IPR033883 | |
| Domain | WWE | 4.49e-03 | 12 | 159 | 2 | PF02825 | |
| Domain | WWE-dom | 4.49e-03 | 12 | 159 | 2 | IPR004170 | |
| Domain | MAPK | 4.49e-03 | 12 | 159 | 2 | PS01351 | |
| Domain | WWE | 4.49e-03 | 12 | 159 | 2 | PS50918 | |
| Domain | MAP_kinase_CS | 4.49e-03 | 12 | 159 | 2 | IPR003527 | |
| Domain | Calpain_III | 4.49e-03 | 12 | 159 | 2 | IPR022683 | |
| Domain | TPR | 4.96e-03 | 129 | 159 | 5 | SM00028 | |
| Domain | ELM2_dom | 5.28e-03 | 13 | 159 | 2 | IPR000949 | |
| Domain | Calpain_III | 5.28e-03 | 13 | 159 | 2 | PF01067 | |
| Domain | Calpain_domain_III | 5.28e-03 | 13 | 159 | 2 | IPR022682 | |
| Domain | ELM2 | 5.28e-03 | 13 | 159 | 2 | PF01448 | |
| Domain | ELM2 | 5.28e-03 | 13 | 159 | 2 | PS51156 | |
| Domain | ELM2 | 5.28e-03 | 13 | 159 | 2 | SM01189 | |
| Domain | TPR_repeat | 5.63e-03 | 133 | 159 | 5 | IPR019734 | |
| Domain | Calpain_cysteine_protease | 6.13e-03 | 14 | 159 | 2 | IPR022684 | |
| Domain | Rho_GTPase_activation_prot | 6.78e-03 | 88 | 159 | 4 | IPR008936 | |
| Domain | FERM_M | 7.03e-03 | 46 | 159 | 3 | PF00373 | |
| Domain | FN3 | 7.21e-03 | 199 | 159 | 6 | PS50853 | |
| Domain | TPR_1 | 7.33e-03 | 90 | 159 | 4 | IPR001440 | |
| Domain | TPR_1 | 7.33e-03 | 90 | 159 | 4 | PF00515 | |
| Domain | Ig-like_fold | EPHB6 NRG1 MXRA5 PDGFRA LINGO3 MFAP3 PTPRC PTPRZ1 ATF7IP KIRREL1 FNDC8 SDK1 PALLD | 7.43e-03 | 706 | 159 | 13 | IPR013783 |
| Domain | Homeodomain-like | 7.66e-03 | 332 | 159 | 8 | IPR009057 | |
| Domain | GRAM | 7.99e-03 | 16 | 159 | 2 | SM00568 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN | RGPD4 TPR RANBP2 RGPD8 RGPD1 RBM39 LMNB1 RGPD3 NUP133 NUP160 | 2.66e-11 | 55 | 119 | 10 | MM14917 |
| Pathway | REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY | 1.25e-09 | 40 | 119 | 8 | MM14945 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS | 1.54e-09 | 41 | 119 | 8 | MM15200 | |
| Pathway | REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS | 1.89e-09 | 42 | 119 | 8 | MM15039 | |
| Pathway | REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA | 2.30e-09 | 43 | 119 | 8 | MM14609 | |
| Pathway | REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS | 4.86e-09 | 47 | 119 | 8 | MM14939 | |
| Pathway | REACTOME_GENE_SILENCING_BY_RNA | 6.87e-09 | 49 | 119 | 8 | MM14837 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS | 8.12e-09 | 50 | 119 | 8 | MM14610 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS | 9.56e-09 | 51 | 119 | 8 | MM15151 | |
| Pathway | REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS | 2.74e-08 | 58 | 119 | 8 | MM15149 | |
| Pathway | REACTOME_SNRNP_ASSEMBLY | 2.74e-08 | 58 | 119 | 8 | MM14736 | |
| Pathway | REACTOME_GLUCOSE_METABOLISM | 2.80e-08 | 82 | 119 | 9 | MM15394 | |
| Pathway | REACTOME_MITOTIC_PROPHASE | RGPD4 TPR RANBP2 RGPD8 RGPD1 RBM39 LMNB1 RGPD3 NUP133 NUP160 | 4.08e-08 | 114 | 119 | 10 | MM15361 |
| Pathway | REACTOME_SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS | 6.87e-08 | 65 | 119 | 8 | MM15147 | |
| Pathway | REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE | 1.73e-07 | 73 | 119 | 8 | MM14948 | |
| Pathway | BIOCARTA_RANBP2_PATHWAY | 3.09e-07 | 18 | 119 | 5 | MM1549 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS | 5.19e-07 | 84 | 119 | 8 | MM14929 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM | 6.23e-07 | 86 | 119 | 8 | MM15413 | |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS | 1.05e-06 | 92 | 119 | 8 | MM14951 | |
| Pathway | REACTOME_AMPLIFICATION_OF_SIGNAL_FROM_THE_KINETOCHORES | 1.98e-06 | 100 | 119 | 8 | MM14561 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_FORMINS | 2.95e-06 | 141 | 119 | 9 | MM15266 | |
| Pathway | REACTOME_MITOTIC_SPINDLE_CHECKPOINT | 6.45e-06 | 117 | 119 | 8 | MM15387 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | RGPD4 ARHGAP32 RANBP2 STARD8 RGPD8 TAGAP DVL1 RGPD1 MCF2 RBM39 TIAM2 LMNB1 RGPD3 NUP133 ARHGAP29 TOR1AIP1 NUP160 DYNC1H1 | 8.08e-06 | 649 | 119 | 18 | MM15690 |
| Pathway | REACTOME_SUMOYLATION | 1.29e-05 | 169 | 119 | 9 | MM14919 | |
| Pathway | REACTOME_RESOLUTION_OF_SISTER_CHROMATID_COHESION | 1.33e-05 | 129 | 119 | 8 | MM14894 | |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | RGPD4 TPR RANBP2 RGPD8 RGPD1 HNRNPA1L2 HNRNPA1 RBM39 RGPD3 NUP133 NUP160 | 2.23e-05 | 277 | 119 | 11 | MM15414 |
| Pathway | REACTOME_MITOTIC_METAPHASE_AND_ANAPHASE | RGPD4 RANBP2 RGPD8 RGPD1 RBM39 LMNB1 RGPD3 NUP133 NUP160 DYNC1H1 | 2.87e-05 | 234 | 119 | 10 | MM14898 |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN | 8.18e-05 | 53 | 119 | 5 | M27212 | |
| Pathway | REACTOME_METABOLISM_OF_CARBOHYDRATES | RGPD4 TPR RANBP2 RGPD8 RGPD1 ACAN RGPD3 NUP133 GAPDHS NUP160 | 9.86e-05 | 271 | 119 | 10 | MM15406 |
| Pathway | REACTOME_REGULATION_OF_GLUCOKINASE_BY_GLUCOKINASE_REGULATORY_PROTEIN | 1.45e-04 | 32 | 119 | 4 | M29579 | |
| Pathway | BIOCARTA_AGR_PATHWAY | 1.63e-04 | 33 | 119 | 4 | M6220 | |
| Pathway | REACTOME_EXPORT_OF_VIRAL_RIBONUCLEOPROTEINS_FROM_NUCLEUS | 1.63e-04 | 33 | 119 | 4 | M27016 | |
| Pathway | REACTOME_NUCLEAR_IMPORT_OF_REV_PROTEIN | 1.84e-04 | 34 | 119 | 4 | M27041 | |
| Pathway | REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS | 2.06e-04 | 35 | 119 | 4 | M27320 | |
| Pathway | REACTOME_SEPARATION_OF_SISTER_CHROMATIDS | 2.29e-04 | 193 | 119 | 8 | MM14890 | |
| Pathway | REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA | 2.31e-04 | 36 | 119 | 4 | M26974 | |
| Pathway | REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY | 2.31e-04 | 36 | 119 | 4 | M27245 | |
| Pathway | REACTOME_INTERACTIONS_OF_VPR_WITH_HOST_CELLULAR_PROTEINS | 2.57e-04 | 37 | 119 | 4 | M1029 | |
| Pathway | REACTOME_INTERACTIONS_OF_REV_WITH_HOST_CELLULAR_PROTEINS | 2.57e-04 | 37 | 119 | 4 | M27038 | |
| Pathway | REACTOME_MITOTIC_PROMETAPHASE | 3.12e-04 | 202 | 119 | 8 | MM15362 | |
| Pathway | REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS | 3.16e-04 | 39 | 119 | 4 | M27238 | |
| Pathway | REACTOME_RHO_GTPASE_EFFECTORS | 3.27e-04 | 257 | 119 | 9 | MM14755 | |
| Pathway | REACTOME_NS1_MEDIATED_EFFECTS_ON_HOST_PATHWAYS | 3.84e-04 | 41 | 119 | 4 | M29574 | |
| Pathway | REACTOME_M_PHASE | RGPD4 TPR RANBP2 RGPD8 RGPD1 RBM39 LMNB1 RGPD3 NUP133 NUP160 DYNC1H1 | 4.30e-04 | 387 | 119 | 11 | MM15364 |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS | 4.62e-04 | 43 | 119 | 4 | M26975 | |
| Pathway | REACTOME_CELL_CYCLE_CHECKPOINTS | 4.81e-04 | 271 | 119 | 9 | MM15388 | |
| Pathway | REACTOME_VIRAL_MESSENGER_RNA_SYNTHESIS | 5.05e-04 | 44 | 119 | 4 | M109 | |
| Pathway | WP_REGULATORY_CIRCUITS_OF_STAT3_SIGNALING | 5.09e-04 | 78 | 119 | 5 | M39824 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS | 5.99e-04 | 46 | 119 | 4 | M27397 | |
| Pathway | REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS | 6.51e-04 | 47 | 119 | 4 | M27395 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HIV_VPR_TAT_TO_TNF_JNK_SIGNALING_PATHWAY | 6.95e-04 | 5 | 119 | 2 | M47570 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_ERBB4_TO_NRG_ERBB4_PI3K_SIGNALING_PATHWAY | 6.95e-04 | 5 | 119 | 2 | M48991 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_PARAQUAT_TO_FAS_JNK_SIGNALING_PATHWAY | 6.95e-04 | 5 | 119 | 2 | M49021 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HTLV_1_TAX_TO_TNF_JNK_SIGNALING_PATHWAY | 6.95e-04 | 5 | 119 | 2 | M49005 | |
| Pathway | REACTOME_GLUCOSE_METABOLISM | 7.54e-04 | 85 | 119 | 5 | M1870 | |
| Pathway | REACTOME_GENE_EXPRESSION_TRANSCRIPTION | RGPD4 TPR RANBP2 BRIP1 RGPD8 PHF19 RGPD1 E2F7 RICTOR NUAK1 ATF7IP RGPD3 ZNF804B NUP133 TAF1 SNAPC4 TAF1L NUP160 RNF111 | 8.94e-04 | 1022 | 119 | 19 | MM15436 |
| Pathway | REACTOME_RHOD_GTPASE_CYCLE | 1.03e-03 | 53 | 119 | 4 | M41811 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_TNF_JNK_SIGNALING_PATHWAY | 1.04e-03 | 6 | 119 | 2 | M47680 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_IRE1A_JNK_SIGNALING_PATHWAY | 1.04e-03 | 6 | 119 | 2 | M47698 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_DJ1_TO_FAS_JNK_SIGNALING_PATWHAY | 1.04e-03 | 6 | 119 | 2 | M47712 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | ARHGAP32 RANBP2 STARD8 TAGAP DVL1 MCF2 DBN1 TIAM2 LMNB1 NUP133 ARHGAP29 PLD1 TOR1AIP1 NUP160 DYNC1H1 | 1.07e-03 | 720 | 119 | 15 | M41838 |
| Pathway | REACTOME_SNRNP_ASSEMBLY | 1.10e-03 | 54 | 119 | 4 | M29594 | |
| Pathway | REACTOME_CELLULAR_RESPONSES_TO_STIMULI | RGPD4 TPR RANBP2 RGPD8 RGPD1 LMNB1 RGPD3 NUP133 MAPK9 MAPK10 NUP160 DYNC1H1 | 1.15e-03 | 505 | 119 | 12 | MM15548 |
| Pathway | REACTOME_CDC42_GTPASE_CYCLE | 1.19e-03 | 94 | 119 | 5 | MM15598 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 1.19e-03 | 140 | 119 | 6 | M587 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR2_4_MAPK_SIGNALING_PATHWAY | 1.32e-03 | 26 | 119 | 3 | M47565 | |
| Pathway | KEGG_MEDICUS_REFERENCE_IRE1A_JNK_SIGNALING_PATHWAY | 1.44e-03 | 7 | 119 | 2 | M47697 | |
| Pathway | KEGG_MEDICUS_REFERENCE_FAS_JNK_SIGNALING_PATHWAY | 1.44e-03 | 7 | 119 | 2 | M47711 | |
| Pathway | WP_FOCAL_ADHESION | 1.49e-03 | 199 | 119 | 7 | M39402 | |
| Pathway | KEGG_FOCAL_ADHESION | 1.49e-03 | 199 | 119 | 7 | M7253 | |
| Pathway | REACTOME_TRNA_PROCESSING_IN_THE_NUCLEUS | 1.54e-03 | 59 | 119 | 4 | M27606 | |
| Pathway | REACTOME_RHOA_GTPASE_CYCLE | 1.64e-03 | 149 | 119 | 6 | M41805 | |
| Pathway | REACTOME_HIV_LIFE_CYCLE | 1.64e-03 | 149 | 119 | 6 | M4076 | |
| Pathway | REACTOME_CELL_CYCLE | RGPD4 TPR RANBP2 BRIP1 RGPD8 ATRX RGPD1 RBM39 LMNB1 RGPD3 NUP133 NUP160 DYNC1H1 | 1.72e-03 | 603 | 119 | 13 | MM14635 |
| Pathway | KEGG_PATHWAYS_IN_CANCER | 1.73e-03 | 325 | 119 | 9 | M12868 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_METALS_TO_JNK_SIGNALING_PATHWAY | 1.91e-03 | 8 | 119 | 2 | M47814 | |
| Pathway | REACTOME_PI3K_EVENTS_IN_ERBB4_SIGNALING | 1.91e-03 | 8 | 119 | 2 | MM14532 | |
| Pathway | REACTOME_CDC42_GTPASE_CYCLE | 2.01e-03 | 155 | 119 | 6 | M41808 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NUCLEAR_EXPORT_OF_MRNA | 2.02e-03 | 30 | 119 | 3 | M47752 | |
| Pathway | REACTOME_RHOD_GTPASE_CYCLE | 2.08e-03 | 64 | 119 | 4 | MM15601 | |
| Pathway | BIOCARTA_AGR_PATHWAY | 2.22e-03 | 31 | 119 | 3 | MM1343 | |
| Pathway | PID_NEPHRIN_NEPH1_PATHWAY | 2.22e-03 | 31 | 119 | 3 | M193 | |
| Pathway | PID_WNT_NONCANONICAL_PATHWAY | 2.43e-03 | 32 | 119 | 3 | M23 | |
| Pathway | REACTOME_P75NTR_REGULATES_AXONOGENESIS | 2.45e-03 | 9 | 119 | 2 | MM14745 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_NE_REASSEMBLY | 2.59e-03 | 68 | 119 | 4 | MM14921 | |
| Pathway | KEGG_PANCREATIC_CANCER | 2.88e-03 | 70 | 119 | 4 | M9726 | |
| Pathway | REACTOME_SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS | 3.03e-03 | 71 | 119 | 4 | M27394 | |
| Pathway | REACTOME_PI3K_EVENTS_IN_ERBB4_SIGNALING | 3.04e-03 | 10 | 119 | 2 | M568 | |
| Pathway | REACTOME_ACTIVATION_OF_THE_AP_1_FAMILY_OF_TRANSCRIPTION_FACTORS | 3.04e-03 | 10 | 119 | 2 | MM15135 | |
| Pathway | REACTOME_P75NTR_REGULATES_AXONOGENESIS | 3.04e-03 | 10 | 119 | 2 | M27073 | |
| Pathway | REACTOME_ACTIVATION_OF_THE_AP_1_FAMILY_OF_TRANSCRIPTION_FACTORS | 3.04e-03 | 10 | 119 | 2 | M13962 | |
| Pathway | WP_CHROMOSOMAL_AND_MICROSATELLITE_INSTABILITY_IN_COLORECTAL_CANCER | 3.36e-03 | 73 | 119 | 4 | M39758 | |
| Pathway | WP_WNT_SIGNALING_IN_KIDNEY_DISEASE | 3.42e-03 | 36 | 119 | 3 | M39699 | |
| Pathway | REACTOME_ISG15_ANTIVIRAL_MECHANISM | 3.52e-03 | 74 | 119 | 4 | M48006 | |
| Pathway | REACTOME_RAC1_GTPASE_CYCLE | 3.67e-03 | 175 | 119 | 6 | MM15599 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NRG_ERBB4_PI3K_SIGNALING_PATHWAY | 3.70e-03 | 11 | 119 | 2 | M47756 | |
| Pathway | REACTOME_ERBB2_ACTIVATES_PTK6_SIGNALING | 3.70e-03 | 11 | 119 | 2 | MM15478 | |
| Pathway | REACTOME_GRB2_EVENTS_IN_ERBB2_SIGNALING | 3.70e-03 | 11 | 119 | 2 | MM14760 | |
| Pathway | REACTOME_SHC1_EVENTS_IN_ERBB4_SIGNALING | 3.70e-03 | 11 | 119 | 2 | MM14533 | |
| Pathway | PID_RAC1_REG_PATHWAY | 3.99e-03 | 38 | 119 | 3 | M241 | |
| Pubmed | RGPD4 TPR RANBP2 HIVEP1 ZNF148 RGPD8 DVL1 RGPD1 RABGAP1 KIAA1671 NEK1 FASN ATF7IP RGPD3 TMF1 TAF1 LRBA UTRN | 1.51e-12 | 418 | 163 | 18 | 34709266 | |
| Pubmed | ARHGAP32 RANBP2 ANK3 DVL1 KIAA1549 HNRNPA1 KIAA1671 CCSER2 NUP133 KIRREL1 LRBA ACBD3 UTRN TOR1AIP1 ZC3HAV1 | 2.24e-12 | 263 | 163 | 15 | 34702444 | |
| Pubmed | Peering through the pore: nuclear pore complex structure, assembly, and function. | 8.50e-12 | 38 | 163 | 8 | 12791264 | |
| Pubmed | Ankyrin-G induces nucleoporin Nup358 to associate with the axon initial segment of neurons. | 1.61e-11 | 13 | 163 | 6 | 31427429 | |
| Pubmed | 4.43e-11 | 7 | 163 | 5 | 9037092 | ||
| Pubmed | Complex genomic rearrangements lead to novel primate gene function. | 4.43e-11 | 7 | 163 | 5 | 15710750 | |
| Pubmed | Genomic organization, expression, and localization of murine Ran-binding protein 2 (RanBP2) gene. | 4.43e-11 | 7 | 163 | 5 | 11353387 | |
| Pubmed | 4.43e-11 | 7 | 163 | 5 | 30944974 | ||
| Pubmed | 4.43e-11 | 7 | 163 | 5 | 38838144 | ||
| Pubmed | Retina-specifically expressed novel subtypes of bovine cyclophilin. | 4.43e-11 | 7 | 163 | 5 | 7559465 | |
| Pubmed | Mst1, RanBP2 and eIF4G are new markers for in vivo PI3K activation in murine and human prostate. | 4.43e-11 | 7 | 163 | 5 | 17372272 | |
| Pubmed | 4.43e-11 | 7 | 163 | 5 | 38657106 | ||
| Pubmed | 4.43e-11 | 7 | 163 | 5 | 21205196 | ||
| Pubmed | 4.43e-11 | 7 | 163 | 5 | 18949001 | ||
| Pubmed | 4.43e-11 | 7 | 163 | 5 | 25187515 | ||
| Pubmed | 4.43e-11 | 7 | 163 | 5 | 8603673 | ||
| Pubmed | 4.43e-11 | 7 | 163 | 5 | 26632511 | ||
| Pubmed | 4.43e-11 | 7 | 163 | 5 | 24403063 | ||
| Pubmed | 4.43e-11 | 7 | 163 | 5 | 23818861 | ||
| Pubmed | 4.43e-11 | 7 | 163 | 5 | 23536549 | ||
| Pubmed | 4.43e-11 | 7 | 163 | 5 | 12191015 | ||
| Pubmed | 4.43e-11 | 7 | 163 | 5 | 22821000 | ||
| Pubmed | 4.43e-11 | 7 | 163 | 5 | 20682751 | ||
| Pubmed | TPR RIPOR2 AHI1 STARD8 ANK3 ATRX TAGAP LMTK2 RICTOR TACC2 TRIP12 DNTTIP2 TIAM2 SBNO2 KAT7 MFAP3 ARID1B PTPRC NKAPD1 CCSER2 CRYBG1 PLD1 UTRN BRWD1 RAB11FIP3 | 5.22e-11 | 1084 | 163 | 25 | 11544199 | |
| Pubmed | Comprehensive identification of phosphorylation sites in postsynaptic density preparations. | RGPD4 RANBP2 RGPD8 ATRX RGPD1 HNRNPA1L2 HNRNPA1 RBM39 LMNB1 PTPRZ1 RGPD3 EPB41L1 BRWD1 | 8.17e-11 | 231 | 163 | 13 | 16452087 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | TPR RANBP2 ZNF148 ATRX TACC2 DBN1 HNRNPA1 RBM39 DNTTIP2 KIAA1671 CRACD NEK1 SETD2 FASN SAFB ATF7IP NUP133 LRBA ACBD3 UTRN TOR1AIP1 PALLD ZC3HAV1 | 9.29e-11 | 934 | 163 | 23 | 33916271 |
| Pubmed | The nucleoporin RanBP2 tethers the cAMP effector Epac1 and inhibits its catalytic activity. | 1.18e-10 | 8 | 163 | 5 | 21670213 | |
| Pubmed | 1.18e-10 | 8 | 163 | 5 | 27412403 | ||
| Pubmed | Mice lacking Ran binding protein 1 are viable and show male infertility. | 1.18e-10 | 8 | 163 | 5 | 21310149 | |
| Pubmed | The distribution of phosphorylated SR proteins and alternative splicing are regulated by RANBP2. | 1.18e-10 | 8 | 163 | 5 | 22262462 | |
| Pubmed | Zap70 and downstream RanBP2 are required for the exact timing of the meiotic cell cycle in oocytes. | 1.18e-10 | 8 | 163 | 5 | 28745977 | |
| Pubmed | ANK3 VPS13C MUC16 RICTOR FLG2 TRIP12 HNRNPA1 CEP350 KIAA1671 LMNB1 ATF7IP TMF1 KIRREL1 DCLRE1A PLD1 LRBA TOR1AIP1 SDK1 NUP160 DYNC1H1 ZC3HAV1 | 1.22e-10 | 777 | 163 | 21 | 35844135 | |
| Pubmed | TPR ARHGAP32 RANBP2 RIPOR2 HIVEP1 ANK3 LAMB1 MUC12 CEP350 RTKN2 ATF7IP ERRFI1 NKTR TAF1 MAPK9 MAPK10 RNF111 | 1.65e-10 | 486 | 163 | 17 | 20936779 | |
| Pubmed | Resolution of sister centromeres requires RanBP2-mediated SUMOylation of topoisomerase IIalpha. | 2.64e-10 | 9 | 163 | 5 | 18394993 | |
| Pubmed | 2.64e-10 | 9 | 163 | 5 | 28100513 | ||
| Pubmed | 2.64e-10 | 9 | 163 | 5 | 17887960 | ||
| Pubmed | 2.64e-10 | 9 | 163 | 5 | 11553612 | ||
| Pubmed | 2.64e-10 | 9 | 163 | 5 | 10601307 | ||
| Pubmed | 2.64e-10 | 9 | 163 | 5 | 9733766 | ||
| Pubmed | 2.64e-10 | 9 | 163 | 5 | 28877029 | ||
| Pubmed | 5.26e-10 | 10 | 163 | 5 | 27160050 | ||
| Pubmed | Parkin ubiquitinates and promotes the degradation of RanBP2. | 5.26e-10 | 10 | 163 | 5 | 16332688 | |
| Pubmed | Cyclophilin-related protein RanBP2 acts as chaperone for red/green opsin. | 5.26e-10 | 10 | 163 | 5 | 8857542 | |
| Pubmed | 5.26e-10 | 10 | 163 | 5 | 21859863 | ||
| Pubmed | 9.60e-10 | 11 | 163 | 5 | 17069463 | ||
| Pubmed | An Rtn4/Nogo-A-interacting micropeptide modulates synaptic plasticity with age. | 9.60e-10 | 11 | 163 | 5 | 35771867 | |
| Pubmed | 9.60e-10 | 11 | 163 | 5 | 34110283 | ||
| Pubmed | TPR ZNF148 ANK3 DVL1 DBN1 KIAA1671 NEK1 SETD2 FASN ARID1B LMNB1 TAF1 LRBA PALLD DYNC1H1 ZC3HAV1 RGPD5 | 1.05e-09 | 549 | 163 | 17 | 38280479 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | RGPD4 TPR RANBP2 RGPD8 RGPD1 LAMB1 TACC2 HNRNPA1L2 TSSC4 RBM39 CEP350 RTKN2 FASN ARID1B LMNB1 RGPD3 CCSER2 NUP133 TOR1AIP1 NUP160 DYNC1H1 USP47 CREB3L2 RGPD5 | 1.06e-09 | 1155 | 163 | 24 | 20360068 |
| Pubmed | TPR RANBP2 ZNF148 TACC2 TRIP12 KAT7 FASN SAFB NUP133 TMF1 PALLD ANKS3 EPB41L1 USP47 SH3BP5 ZC3HAV1 | 2.29e-09 | 503 | 163 | 16 | 16964243 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | RANBP2 ATRX LMTK2 RICTOR TRIP12 RBM39 DNTTIP2 SETD2 ARID1B CCSER2 NUP133 NKTR TRMT1L NUP160 ZC3HAV1 | 2.93e-09 | 440 | 163 | 15 | 34244565 |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | TPR RANBP2 BRIP1 HIVEP1 ZNF148 ATRX HNRNPA1L2 DBN1 TRIP12 HNRNPA1 RBM39 DNTTIP2 SETD2 ARID1B SAFB LMNB1 ATF7IP ATAD2B TAF1 TAF1L TOR1AIP1 | 4.73e-09 | 954 | 163 | 21 | 36373674 |
| Pubmed | RGPD4 TPR ARHGAP32 RANBP2 PDE4A RGPD8 ANK3 APC2 RGPD1 DBN1 SHANK3 DLGAP3 LMNB1 SSH1 ATF7IP SPHKAP RGPD3 UNC79 DYNC1H1 EPB41L1 SH3BP5 | 5.58e-09 | 963 | 163 | 21 | 28671696 | |
| Pubmed | 6.15e-09 | 15 | 163 | 5 | 14697343 | ||
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | TPR RANBP2 ATRX HNRNPA1L2 RAD54L2 FASN SAFB ATF7IP TAF1 TRMT1L PALLD NUP160 DYNC1H1 | 6.75e-09 | 332 | 163 | 13 | 32786267 |
| Pubmed | 7.62e-09 | 86 | 163 | 8 | 37253089 | ||
| Pubmed | 1.61e-08 | 7 | 163 | 4 | 17098863 | ||
| Pubmed | RGPD4 TPR ARHGAP32 RANBP2 RGPD8 ANK3 CAPN2 DVL1 RGPD1 LMTK2 RICTOR TACC2 RABGAP1 DBN1 SHANK3 RBM39 DLGAP3 TNRC18 SAFB SPHKAP RGPD3 EPB41L1 | 2.07e-08 | 1139 | 163 | 22 | 36417873 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | TPR RANBP2 BRIP1 HIVEP1 ZNF148 ATRX RICTOR DBN1 TSSC4 TRIP12 SETD2 FASN SAFB PTPRC SSH1 SNAPC4 USP47 ZC3HAV1 | 2.83e-08 | 774 | 163 | 18 | 15302935 |
| Pubmed | Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer. | RGPD4 RANBP2 PDE4A RGPD8 LAMB1 DBN1 FLG2 HNRNPA1 SHANK3 FASN SAFB LMNB1 RGPD3 DYNC1H1 ZC3HAV1 RGPD5 | 4.85e-08 | 626 | 163 | 16 | 33644029 |
| Pubmed | 5.25e-08 | 22 | 163 | 5 | 27717094 | ||
| Pubmed | MIER2 ARHGAP32 STARD8 RICTOR SHANK3 CEP350 NEK1 SETD2 TNRC18 SSH1 ADAMTS9 PLEKHH2 PALLD NUP160 | 9.71e-08 | 493 | 163 | 14 | 15368895 | |
| Pubmed | 1.12e-07 | 121 | 163 | 8 | 22412018 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | PDE4A PPP1R3B DVL1 LMTK2 PIP5K1C TIAM2 SBNO2 DACT1 FASN TNRC18 HEG1 AATK SSH1 NUAK1 LMX1B CHD5 LRBA SNAPC4 DYNC1H1 RAB11FIP3 | 2.70e-07 | 1105 | 163 | 20 | 35748872 |
| Pubmed | Protein phosphatase 1γ isoforms linked interactions in the brain. | 2.88e-07 | 57 | 163 | 6 | 23080069 | |
| Pubmed | 4.03e-07 | 4 | 163 | 3 | 9480752 | ||
| Pubmed | 4.52e-07 | 99 | 163 | 7 | 27746211 | ||
| Pubmed | RGPD4 TPR RANBP2 RGPD8 ANK3 RGPD1 MUC16 HNRNPA1L2 DBN1 HNRNPA1 FASN LMNB1 RGPD3 UTRN PALLD DYNC1H1 RGPD5 | 5.27e-07 | 844 | 163 | 17 | 25963833 | |
| Pubmed | ARHGAP32 RANBP2 ANK3 LMTK2 KIAA1549 RICTOR HID1 CEP350 KIAA1671 ARID1B PTPRC SSH1 PTPRZ1 NUP133 TMF1 KIRREL1 MAPK9 UTRN EPB41L1 | 5.43e-07 | 1049 | 163 | 19 | 27880917 | |
| Pubmed | TPR RANBP2 DBN1 FLG2 TRIP12 HNRNPA1 DNTTIP2 KIAA1671 KAT7 SAFB LMNB1 NUP133 KIRREL1 NUP160 ZC3HAV1 | 5.74e-07 | 660 | 163 | 15 | 32780723 | |
| Pubmed | Systematic identification of factors for provirus silencing in embryonic stem cells. | 6.81e-07 | 153 | 163 | 8 | 26365490 | |
| Pubmed | EPHB6 ANK3 ATRX CEP85L APC2 LAMB1 RAD54L2 TRIP12 CEP350 PLEKHH1 ADAMTS9 TAF1 LRBA ACBD3 UTRN DYNC1H1 USP47 ALPL RNF111 SH3BP5 BRWD1 | 6.98e-07 | 1285 | 163 | 21 | 35914814 | |
| Pubmed | 8.76e-07 | 215 | 163 | 9 | 35973513 | ||
| Pubmed | Compartmentalization of the SUMO/RNF4 pathway by SLX4 drives DNA repair. | RANBP2 BRIP1 ATRX HNRNPA1 CEP350 FASN SAFB ATF7IP RGPD3 DCLRE1A DYNC1H1 | 1.09e-06 | 357 | 163 | 11 | 37059091 |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | MIER2 BRIP1 HIVEP1 ZNF148 ATRX TRIP12 DNTTIP2 KAT7 NKAPD1 CHD5 ATAD2B TAF1 SNAPC4 BRWD1 | 1.19e-06 | 608 | 163 | 14 | 36089195 |
| Pubmed | ATG5 is required for B cell polarization and presentation of particulate antigens. | RGPD4 RANBP2 RGPD8 RGPD1 HNRNPA1L2 TSSC4 TBC1D8B TRIP12 HNRNPA1 SAFB PTPRC LMNB1 RGPD3 NKTR ZC3HAV1 | 1.21e-06 | 701 | 163 | 15 | 30196744 |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | HIVEP1 ZNF148 ANK3 RASGRF1 TRIP12 HNRNPA1 RBM39 SAFB LMNB1 PALLD ALPL | 1.22e-06 | 361 | 163 | 11 | 26167880 |
| Pubmed | Proteomic and yeast 2-hybrid screens to identify PTEN binding partners. | 1.32e-06 | 226 | 163 | 9 | 37839992 | |
| Pubmed | Transcription factor Foxp3 and its protein partners form a complex regulatory network. | RGPD4 RANBP2 ZNF148 RGPD8 RGPD1 FASN RGPD3 TAF1 TRMT1L TAF1L DYNC1H1 | 1.54e-06 | 370 | 163 | 11 | 22922362 |
| Pubmed | 1.76e-06 | 234 | 163 | 9 | 36243803 | ||
| Pubmed | Stella is a maternal effect gene required for normal early development in mice. | 2.00e-06 | 6 | 163 | 3 | 14654002 | |
| Pubmed | A new c-Jun N-terminal kinase (JNK)-interacting protein, Sab (SH3BP5), associates with mitochondria. | 2.00e-06 | 6 | 163 | 3 | 12167088 | |
| Pubmed | An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase. | ARHGAP32 ZNF148 RAD54L2 NUP133 ARHGAP29 KIRREL1 TOR1AIP1 NUP160 | 2.31e-06 | 180 | 163 | 8 | 35198878 |
| Pubmed | RANBP2 ZNF148 ATRX PHF19 TRIP12 KAT7 SSH1 NUP133 CRYBG1 TRMT1L UNC79 NUP160 | 2.43e-06 | 469 | 163 | 12 | 27634302 | |
| Pubmed | TPR RANBP2 ZNF148 DBN1 TRIP12 HNRNPA1 RBM39 DNTTIP2 KAT7 FASN SAFB NUP133 PLD1 TRMT1L TOR1AIP1 ZC3HAV1 | 2.65e-06 | 847 | 163 | 16 | 35850772 | |
| Pubmed | TPR RANBP2 VPS13C RABGAP1 DBN1 FASN LMNB1 RGPD3 TMF1 LRBA ACBD3 TOR1AIP1 ZC3HAV1 | 3.11e-06 | 568 | 163 | 13 | 37774976 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | ARHGAP32 HIVEP1 PDGFRA CEP85L LMTK2 RICTOR TRIP12 NUAK2 CEP350 KIAA1671 NEK1 CCSER2 UTRN PALLD EPB41L1 ZC3HAV1 | 3.26e-06 | 861 | 163 | 16 | 36931259 |
| Pubmed | E3 Ligase Trim21 Ubiquitylates and Stabilizes Keratin 17 to Induce STAT3 Activation in Psoriasis. | 3.65e-06 | 135 | 163 | 7 | 29859926 | |
| Pubmed | RGPD4 RALB RANBP2 RGPD8 ATRX RGPD1 HNRNPA1L2 DBN1 RAD54L2 TRIP12 HNRNPA1 DNTTIP2 FASN TNRC18 SAFB LMNB1 CHD5 RGPD3 UGGT2 DLEC1 RGPD5 | 4.27e-06 | 1442 | 163 | 21 | 35575683 | |
| Pubmed | RANBP2 HIVEP1 PPP1R3B GON4L DNTTIP2 DACT1 ARID1B ADAMTS9 NUP133 TAF1 UTRN PALLD | 4.39e-06 | 497 | 163 | 12 | 23414517 | |
| Pubmed | HIVEP1 ANK3 ATRX PPP1R3B TRIP12 ARID1B PTPRC ATF7IP ACBD3 UTRN SDK1 DYNC1H1 RNF111 | 4.77e-06 | 591 | 163 | 13 | 15231748 | |
| Pubmed | 5.45e-06 | 25 | 163 | 4 | 10601273 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | TPR RANBP2 CAPN2 RICTOR TSSC4 TRIP12 HNRNPA1 RBM39 DNTTIP2 KAT7 FASN SAFB LMNB1 NUP133 PRMT3 UTRN PALLD NUP160 DYNC1H1 ZC3HAV1 | 5.92e-06 | 1353 | 163 | 20 | 29467282 |
| Pubmed | 6.01e-06 | 272 | 163 | 9 | 31010829 | ||
| Pubmed | 6.41e-06 | 26 | 163 | 4 | 12228227 | ||
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | ARHGAP32 ANK3 APC2 RAD54L2 PIP5K1C TRIP12 KIAA1671 TNRC18 AATK CHD5 DYNC1H1 | 6.48e-06 | 430 | 163 | 11 | 35044719 |
| Pubmed | Interaction network of human early embryonic transcription factors. | RANBP2 HIVEP1 ZNF148 RGPD1 RAD54L2 FLG2 KIAA1671 ARID1B TNRC18 TAF1 | 6.78e-06 | 351 | 163 | 10 | 38297188 |
| Pubmed | TPR ARHGAP32 RANBP2 ANK3 RICTOR HNRNPA1 FASN LMNB1 ARHGAP29 LRBA PALLD DYNC1H1 EPB41L1 ZC3HAV1 | 6.87e-06 | 708 | 163 | 14 | 39231216 | |
| Pubmed | 6.96e-06 | 209 | 163 | 8 | 36779422 | ||
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | TPR DBN1 FLG2 TRIP12 HNRNPA1 RBM39 DNTTIP2 KIAA1671 FASN SAFB LMNB1 CHD5 NUP133 CRYBG1 TRMT1L GAPDHS NUP160 DYNC1H1 ZC3HAV1 | 7.53e-06 | 1257 | 163 | 19 | 36526897 |
| Interaction | NUP43 interactions | RANBP2 BRIP1 HIVEP1 RGPD8 DVL1 GON4L RICTOR RAD54L2 TRIP12 RBM39 DNTTIP2 SETD2 ARID1B SAFB LMNB1 ATF7IP ATAD2B CCSER2 NUP133 NKTR TRMT1L FAM199X NUP160 RGPD5 | 1.85e-10 | 625 | 161 | 24 | int:NUP43 |
| Interaction | RGPD4 interactions | 2.81e-10 | 22 | 161 | 7 | int:RGPD4 | |
| Interaction | RGPD2 interactions | 1.41e-09 | 27 | 161 | 7 | int:RGPD2 | |
| Interaction | RGPD1 interactions | 4.76e-09 | 49 | 161 | 8 | int:RGPD1 | |
| Interaction | RNF43 interactions | ARHGAP32 RANBP2 ANK3 DVL1 KIAA1549 HNRNPA1 KIAA1671 CHD5 CCSER2 NUP133 KIRREL1 LRBA ACBD3 UTRN TOR1AIP1 NUP160 ZC3HAV1 | 6.01e-08 | 427 | 161 | 17 | int:RNF43 |
| Interaction | RGPD3 interactions | 8.76e-08 | 47 | 161 | 7 | int:RGPD3 | |
| Interaction | NPIPB6 interactions | 2.41e-07 | 18 | 161 | 5 | int:NPIPB6 | |
| Interaction | HDAC1 interactions | MIER2 TPR RANBP2 HIVEP1 ZNF148 ATRX MIER3 DVL1 GON4L RABGAP1 RBM39 KIAA1671 DACT1 NEK1 FASN TNRC18 LMNB1 CHD5 TMF1 PRMT3 TAF1 LRBA MAPK9 MAPK10 UTRN USP47 | 7.27e-07 | 1108 | 161 | 26 | int:HDAC1 |
| Interaction | NUMA1 interactions | RANBP2 DCAF8L2 DVL1 HNRNPA1L2 TRIP12 HNRNPA1 SHANK3 RBM39 KAT7 ATAD2B RGPD3 NUP133 PRMT3 NUP160 DYNC1H1 EPB41L1 | 1.17e-06 | 469 | 161 | 16 | int:NUMA1 |
| Interaction | RGPD8 interactions | 2.09e-06 | 74 | 161 | 7 | int:RGPD8 | |
| Interaction | YWHAE interactions | ARHGAP32 AHI1 HIVEP1 RASGRF1 CEP85L CAPN2 HDX RICTOR TACC2 DBN1 TRIP12 HNRNPA1 SHANK3 RBM39 NUAK2 KIAA1671 CRACD NEK1 DLGAP3 LMNB1 SSH1 NUAK1 ERRFI1 CCSER2 LRBA DYNC1H1 EPB41L1 | 2.32e-06 | 1256 | 161 | 27 | int:YWHAE |
| Interaction | SIRT6 interactions | RANBP2 RGPD8 ATRX LMTK2 RICTOR TRIP12 RBM39 DNTTIP2 SETD2 ARID1B CCSER2 NUP133 NKTR TRMT1L PALLD NUP160 ZC3HAV1 RGPD5 | 2.93e-06 | 628 | 161 | 18 | int:SIRT6 |
| Interaction | NAA40 interactions | TPR RANBP2 ZNF148 ATRX TACC2 DBN1 HNRNPA1 RBM39 DNTTIP2 KIAA1671 CRACD NEK1 SETD2 FASN SAFB ATF7IP NUP133 LRBA ACBD3 UTRN TOR1AIP1 PALLD ZC3HAV1 | 3.31e-06 | 978 | 161 | 23 | int:NAA40 |
| Interaction | PFN1 interactions | TPR RANBP2 VPS13C RABGAP1 DBN1 HNRNPA1 RBM39 CEP350 KIAA1671 NEK1 FASN CHD5 ARHGAP29 TMF1 UGGT2 PALLD | 3.37e-06 | 509 | 161 | 16 | int:PFN1 |
| Interaction | GJA1 interactions | ARHGAP32 ANK3 DVL1 LMTK2 KIAA1549 RICTOR RABGAP1 LMNB1 TMF1 KIRREL1 LRBA ACBD3 UTRN TOR1AIP1 SDK1 EPB41L1 ZC3HAV1 | 4.48e-06 | 583 | 161 | 17 | int:GJA1 |
| Interaction | ATG16L1 interactions | ARHGAP32 RANBP2 ANK3 VPS13C DVL1 LMTK2 RICTOR RABGAP1 TSSC4 TBC1D8B TRIP12 HNRNPA1 CEP350 SAFB PTPRC LMNB1 TLR2 CCSER2 TMF1 KIRREL1 NKTR SNAPC4 NUP160 ZC3HAV1 RGPD5 | 5.62e-06 | 1161 | 161 | 25 | int:ATG16L1 |
| Interaction | RYK interactions | DVL1P1 ANK3 DVL1 FREM2 MFAP3 KIRREL1 PLD1 ACBD3 SDK1 DYNC1H1 | 8.19e-06 | 212 | 161 | 10 | int:RYK |
| Interaction | PRC1 interactions | TPR RANBP2 ATRX TACC2 HNRNPA1L2 DBN1 HNRNPA1 SHANK3 DNTTIP2 KIAA1671 KAT7 FASN SAFB LMNB1 CHD5 RGPD3 NUP133 GAPDHS SNAPC4 NUP160 DYNC1H1 ZC3HAV1 | 1.03e-05 | 973 | 161 | 22 | int:PRC1 |
| Interaction | RAB11A interactions | TPR VPS13C LMTK2 KIAA1549 RABGAP1 RBM39 HEG1 LMNB1 SYTL5 NUP133 TMF1 KIRREL1 PLD1 LRBA ACBD3 TOR1AIP1 EPB41L1 SH3BP5 ZC3HAV1 RAB11FIP3 | 1.08e-05 | 830 | 161 | 20 | int:RAB11A |
| Interaction | RGPD5 interactions | 1.20e-05 | 96 | 161 | 7 | int:RGPD5 | |
| Interaction | RAC1 interactions | ARHGAP32 ANK3 RASGRF1 DVL1 KIAA1549 MCF2 RICTOR PIP5K1C SHANK3 RBM39 MFAP3 FASN LMNB1 TLR2 KIRREL1 PLD1 LRBA UTRN TOR1AIP1 NUP160 EPB41L1 ALPL ZC3HAV1 | 1.29e-05 | 1063 | 161 | 23 | int:RAC1 |
| Interaction | YWHAZ interactions | NRG1 ARHGAP32 RIPOR2 HIVEP1 RASGRF1 CEP85L RICTOR TACC2 TRIP12 HNRNPA1 SHANK3 RBM39 NUAK2 KIAA1671 CRACD NEK1 SSH1 AK5 ERRFI1 CCSER2 OSBPL7 ARHGAP29 GAPDHS DYNC1H1 EPB41L1 USP47 | 1.70e-05 | 1319 | 161 | 26 | int:YWHAZ |
| Interaction | YWHAG interactions | ARHGAP32 RIPOR2 HIVEP1 CEP85L LMTK2 RICTOR TRIP12 SHANK3 DNTTIP2 CEP350 KIAA1671 CRACD NEK1 SSH1 NUAK1 ERRFI1 CCSER2 OSBPL7 ARHGAP29 NKTR LRBA UTRN DYNC1H1 EPB41L1 ZC3HAV1 | 1.93e-05 | 1248 | 161 | 25 | int:YWHAG |
| Interaction | RANBP2 interactions | RGPD4 TPR RALB RANBP2 RGPD8 RGPD1 LMNB1 RGPD3 NUP133 TAF1 NUP160 RGPD5 | 3.47e-05 | 361 | 161 | 12 | int:RANBP2 |
| Interaction | EZR interactions | ANK3 KIAA1549 RICTOR HNRNPA1L2 DBN1 RBM39 KIAA1671 CRACD PTPRC LRBA MAPK10 UTRN PALLD EPB41L1 USP47 | 3.88e-05 | 553 | 161 | 15 | int:EZR |
| Interaction | SMC5 interactions | TPR RANBP2 BRIP1 HIVEP1 ZNF148 ATRX HNRNPA1L2 DBN1 TRIP12 HNRNPA1 RBM39 DNTTIP2 SETD2 ARID1B SAFB LMNB1 ATF7IP ATAD2B TAF1 TAF1L TOR1AIP1 | 4.90e-05 | 1000 | 161 | 21 | int:SMC5 |
| Interaction | KCNQ2 interactions | 5.76e-05 | 84 | 161 | 6 | int:KCNQ2 | |
| Interaction | RAB35 interactions | ARHGAP32 ANK3 VPS13C KIAA1549 RICTOR RABGAP1 LMNB1 KIRREL1 PLD1 ACBD3 UTRN TOR1AIP1 NUP160 EPB41L1 ZC3HAV1 | 5.80e-05 | 573 | 161 | 15 | int:RAB35 |
| Interaction | IFI16 interactions | TPR ZNF148 RGPD8 E2F7 HNRNPA1L2 TRIP12 HNRNPA1 RBM39 DNTTIP2 KAT7 SAFB RGPD3 NUP133 TRMT1L TOR1AIP1 NUP160 ZC3HAV1 | 5.98e-05 | 714 | 161 | 17 | int:IFI16 |
| Interaction | SYNE3 interactions | ARHGAP32 RANBP2 VPS13C LAMB1 CEP350 KIAA1671 LMNB1 CCSER2 NUP133 ARHGAP29 UGGT2 TOR1AIP1 ZC3HAV1 | 6.02e-05 | 444 | 161 | 13 | int:SYNE3 |
| Interaction | CEP135 interactions | ARHGAP32 CEP85L DVL1 CEP350 KIAA1671 DACT1 CCSER2 ARHGAP29 PLD1 TOR1AIP1 | 6.90e-05 | 272 | 161 | 10 | int:CEP135 |
| Interaction | CAV1 interactions | ARHGAP32 ANK3 PDGFRA CAPN2 LMTK2 KIAA1549 RICTOR DBN1 FASN TMF1 KIRREL1 PLD1 LRBA ACBD3 UTRN EPB41L1 ZC3HAV1 | 7.09e-05 | 724 | 161 | 17 | int:CAV1 |
| Interaction | BTF3 interactions | RGPD4 RANBP2 PDE4A RGPD8 ANK3 LAMB1 DBN1 FLG2 HNRNPA1 SHANK3 FASN SAFB LMNB1 RGPD3 NUP133 DYNC1H1 ZC3HAV1 RGPD5 | 7.31e-05 | 799 | 161 | 18 | int:BTF3 |
| Interaction | AFDN interactions | EPHB6 ARHGAP32 RICTOR DBN1 HNRNPA1 KIAA1671 ARHGAP29 TMF1 KIRREL1 UTRN SDK1 | 7.82e-05 | 333 | 161 | 11 | int:AFDN |
| Interaction | ERG interactions | HIVEP1 ZNF148 DBN1 RAD54L2 TRIP12 HNRNPA1 ARID1B ATF7IP RNF111 | 7.89e-05 | 223 | 161 | 9 | int:ERG |
| Interaction | SUMO2 interactions | TPR RANBP2 ATRX HNRNPA1L2 RAD54L2 TRIP12 FASN SAFB ATF7IP TAF1 TRMT1L PALLD NUP160 DYNC1H1 RNF111 | 8.20e-05 | 591 | 161 | 15 | int:SUMO2 |
| Interaction | SH3BP5 interactions | 9.15e-05 | 30 | 161 | 4 | int:SH3BP5 | |
| Interaction | NUP50 interactions | RANBP2 BRIP1 ZNF148 RGPD8 LMNB1 NUP133 TAF1 TOR1AIP1 NUP160 EPB41L1 USP47 | 9.66e-05 | 341 | 161 | 11 | int:NUP50 |
| Interaction | PHF21A interactions | TPR RANBP2 HIVEP1 DVL1 RABGAP1 KIAA1671 NEK1 TMF1 TAF1 LRBA UTRN | 1.02e-04 | 343 | 161 | 11 | int:PHF21A |
| Interaction | FBXW11 interactions | RANBP2 HIVEP1 STARD8 PDGFRA HNRNPA1 NUAK2 AATK SSH1 NUAK1 PLEKHH2 PALLD DYNC1H1 USP47 | 1.14e-04 | 473 | 161 | 13 | int:FBXW11 |
| Interaction | HDHD2 interactions | 1.19e-04 | 32 | 161 | 4 | int:HDHD2 | |
| Interaction | DUSP19 interactions | 1.21e-04 | 96 | 161 | 6 | int:DUSP19 | |
| Interaction | MCM2 interactions | RGPD4 TPR RANBP2 RGPD8 ANK3 ATRX RGPD1 MUC16 HNRNPA1L2 HNRNPA1 RBM39 KAT7 FASN LMNB1 NUAK1 RGPD3 ACBD3 UTRN PALLD DYNC1H1 RGPD5 | 1.47e-04 | 1081 | 161 | 21 | int:MCM2 |
| Interaction | BTRC interactions | TPR HIVEP1 STARD8 PHF19 DVL1 DBN1 FLG2 HNRNPA1 RBM39 NUAK2 DACT1 SAFB AATK NUAK1 MAPK9 PALLD USP47 | 1.61e-04 | 775 | 161 | 17 | int:BTRC |
| Interaction | NXF2 interactions | 1.72e-04 | 65 | 161 | 5 | int:NXF2 | |
| Interaction | YWHAB interactions | ARHGAP32 HIVEP1 RASGRF1 CEP85L RICTOR TRIP12 HNRNPA1 SHANK3 CEP350 KIAA1671 DACT1 NEK1 LMNB1 SSH1 NUAK1 ERRFI1 CCSER2 DYNC1H1 EPB41L1 USP47 | 1.75e-04 | 1014 | 161 | 20 | int:YWHAB |
| Interaction | SNRNP40 interactions | BRIP1 HIVEP1 DVL1 GON4L TSSC4 HNRNPA1 RBM39 DNTTIP2 SETD2 ARID1B LMNB1 NKAPD1 ATAD2B NKTR TRMT1L | 1.86e-04 | 637 | 161 | 15 | int:SNRNP40 |
| Interaction | YWHAH interactions | ARHGAP32 HIVEP1 CEP85L LMTK2 RICTOR TRIP12 NUAK2 CEP350 KIAA1671 NEK1 SSH1 NUAK1 ERRFI1 CCSER2 DCLRE1A NKTR LRBA UTRN PALLD EPB41L1 ZC3HAV1 | 1.91e-04 | 1102 | 161 | 21 | int:YWHAH |
| Interaction | OCLN interactions | ARHGAP32 ANK3 DVL1 LMTK2 KIAA1549 RICTOR KIAA1671 CCSER2 KIRREL1 ACBD3 UTRN EPB41L1 ZC3HAV1 | 1.96e-04 | 500 | 161 | 13 | int:OCLN |
| Interaction | CIT interactions | TPR ARHGAP32 RANBP2 HNRNPA1L2 DBN1 TRIP12 HNRNPA1 SHANK3 RBM39 DNTTIP2 KIAA1671 KAT7 FASN SAFB LMNB1 RGPD3 NUP133 NKTR TRMT1L GAPDHS GRAMD1C TOR1AIP1 NUP160 DYNC1H1 ZC3HAV1 | 2.14e-04 | 1450 | 161 | 25 | int:CIT |
| Interaction | RCC1 interactions | 2.17e-04 | 201 | 161 | 8 | int:RCC1 | |
| Interaction | SNX4 interactions | 2.28e-04 | 69 | 161 | 5 | int:SNX4 | |
| Interaction | CENPA interactions | HIVEP1 ZNF148 ATRX TRIP12 DNTTIP2 KAT7 LMNB1 TAF1 TOR1AIP1 NUP160 BRWD1 | 2.31e-04 | 377 | 161 | 11 | int:CENPA |
| Interaction | YWHAQ interactions | TPR ARHGAP32 CEP85L RICTOR TRIP12 HNRNPA1 SHANK3 RBM39 CEP350 KIAA1671 NEK1 FASN LMNB1 SSH1 ERRFI1 CCSER2 LRBA UNC79 DYNC1H1 EPB41L1 USP47 | 2.32e-04 | 1118 | 161 | 21 | int:YWHAQ |
| Interaction | CSNK2A1 interactions | ATRX PHF19 DVL1 RICTOR SHANK3 RBM39 KAT7 FASN SAFB PTPRC NKAPD1 NUP133 NKTR TAF1 SNAPC4 GRAMD1C TOR1AIP1 ANKS3 RNF111 | 2.33e-04 | 956 | 161 | 19 | int:CSNK2A1 |
| Interaction | MAPK8IP3 interactions | 2.43e-04 | 70 | 161 | 5 | int:MAPK8IP3 | |
| Interaction | MKRN2 interactions | AHI1 ATRX LAMB1 DBN1 NKAPD1 TAF1 PLD1 PLEKHH2 SDK1 DYNC1H1 ZC3HAV1 | 2.77e-04 | 385 | 161 | 11 | int:MKRN2 |
| Interaction | TSKS interactions | 2.87e-04 | 40 | 161 | 4 | int:TSKS | |
| Interaction | AGAP2 interactions | 2.92e-04 | 210 | 161 | 8 | int:AGAP2 | |
| Interaction | SIPA1 interactions | 3.16e-04 | 41 | 161 | 4 | int:SIPA1 | |
| Interaction | CFAP184 interactions | 3.30e-04 | 162 | 161 | 7 | int:CFAP184 | |
| Interaction | IK interactions | 3.42e-04 | 215 | 161 | 8 | int:IK | |
| Interaction | CDC42 interactions | ARHGAP32 STARD8 ANK3 KIAA1549 MCF2 RICTOR MUC12 DBN1 HNRNPA1 RBM39 MFAP3 LMNB1 ERRFI1 ARHGAP29 KIRREL1 PLD1 MAPK9 ACBD3 UTRN TOR1AIP1 PALLD EPB41L1 ALPL | 3.50e-04 | 1323 | 161 | 23 | int:CDC42 |
| Interaction | LCK interactions | ARHGAP32 ANK3 LMTK2 E2F7 KIAA1549 RICTOR KIAA1671 SAFB PTPRC ACBD3 UTRN EPB41L1 | 3.56e-04 | 463 | 161 | 12 | int:LCK |
| Interaction | GSK3A interactions | RGPD1 RICTOR CEP350 KIAA1671 NEK1 TNRC18 NUP133 ARHGAP29 CRYBG1 PRMT3 UTRN PALLD | 3.63e-04 | 464 | 161 | 12 | int:GSK3A |
| Interaction | ESRP1 interactions | 3.80e-04 | 77 | 161 | 5 | int:ESRP1 | |
| Interaction | NUPR1 interactions | TPR RANBP2 DBN1 FLG2 TRIP12 HNRNPA1 DNTTIP2 KIAA1671 KAT7 SAFB LMNB1 NUP133 KIRREL1 NUP160 ZC3HAV1 | 3.91e-04 | 683 | 161 | 15 | int:NUPR1 |
| Interaction | TMEM17 interactions | ANK3 DVL1 KIAA1549 MFAP3 KIRREL1 LRBA ACBD3 UTRN TOR1AIP1 EPB41L1 ZC3HAV1 | 4.16e-04 | 404 | 161 | 11 | int:TMEM17 |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 1.06e-05 | 161 | 118 | 8 | 593 | |
| GeneFamily | Nucleoporins | 5.38e-05 | 32 | 118 | 4 | 1051 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 1.07e-04 | 115 | 118 | 6 | 769 | |
| GeneFamily | C2 domain containing|Calpains | 1.16e-04 | 15 | 118 | 3 | 975 | |
| GeneFamily | Rho GTPase activating proteins|BCH domain containing | 3.15e-04 | 50 | 118 | 4 | 721 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 3.94e-04 | 53 | 118 | 4 | 532 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 4.08e-04 | 206 | 118 | 7 | 682 | |
| GeneFamily | Fibronectin type III domain containing | 6.37e-04 | 160 | 118 | 6 | 555 | |
| GeneFamily | Receptor Tyrosine Kinases|CD molecules | 2.25e-03 | 40 | 118 | 3 | 321 | |
| GeneFamily | Mitogen-activated protein kinases | 3.14e-03 | 13 | 118 | 2 | 651 | |
| GeneFamily | WD repeat domain containing|GRAM domain containing|BEACH domain containing | 3.14e-03 | 13 | 118 | 2 | 1146 | |
| GeneFamily | Ankyrin repeat domain containing|FERM domain containing | 4.25e-03 | 50 | 118 | 3 | 1293 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 5.39e-03 | 17 | 118 | 2 | 486 | |
| GeneFamily | Cyclophilin peptidylprolyl isomerases | 6.72e-03 | 19 | 118 | 2 | 909 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | TPR RANBP2 RIPOR2 ZNF148 ATRX PHF19 TAGAP CEP85L VPS13C CAPN2 RICTOR TRIP12 RBM39 DNTTIP2 SBNO2 CEP350 SETD2 HEG1 PTPRC SSH1 ATF7IP CCSER2 TMF1 CRYBG1 LRBA UTRN TOR1AIP1 DYNC1H1 USP47 ZC3HAV1 BRWD1 | 2.38e-09 | 1492 | 162 | 31 | M40023 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | NRG1 RANBP2 HIVEP1 ZNF148 ATRX RABGAP1 TRIP12 RBM39 CEP350 NEK1 SETD2 HEG1 LMNB1 NUAK1 ATAD2B CCSER2 NUP133 ARHGAP29 PRMT3 ACBD3 NUP160 CREB3L2 | 1.68e-08 | 856 | 162 | 22 | M4500 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | NRG1 HIVEP1 ZNF148 ATRX RABGAP1 TRIP12 RBM39 CEP350 SETD2 HEG1 NUAK1 ATAD2B CCSER2 ARHGAP29 PRMT3 CREB3L2 | 3.59e-08 | 466 | 162 | 16 | M13522 |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_7DY_NEGATIVE | RGPD4 RANBP2 RGPD8 ANK3 TAGAP MIER3 RGPD1 GON4L RICTOR HNRNPA1 RBM39 SBNO2 ATAD2B RGPD3 NKTR RGPD5 | 4.54e-08 | 474 | 162 | 16 | M40991 |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_UP | 1.75e-06 | 33 | 162 | 5 | MM477 | |
| Coexpression | GABRIELY_MIR21_TARGETS | ATRX PPP1R3B RABGAP1 NEK1 ATAD2B CRYBG1 TAF1 PLD1 UTRN PALLD USP47 | 1.98e-06 | 289 | 162 | 11 | M2196 |
| Coexpression | KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_UP | ZCCHC24 TPR TAGAP CAPN2 MIER3 E2F7 DBN1 RBM39 PLEKHH1 NEK1 PTPRC SSH1 ATAD2B ERRFI1 OSBPL7 UGGT2 PRMT3 UTRN NUP160 | 6.21e-06 | 942 | 162 | 19 | M8144 |
| Coexpression | GAUTAM_EYE_IRIS_CILIARY_BODY_MEG3_HIGH_FIBROBLASTS | 6.75e-06 | 113 | 162 | 7 | M43610 | |
| Coexpression | TABULA_MURIS_SENIS_TRACHEA_GRANULOCYTE_AGEING | 6.75e-06 | 43 | 162 | 5 | MM3857 | |
| Coexpression | LAKE_ADULT_KIDNEY_C11_THIN_ASCENDING_LIMB | 1.08e-05 | 169 | 162 | 8 | M39230 | |
| Coexpression | GAO_LARGE_INTESTINE_ADULT_CJ_IMMUNE_CELLS | ZCCHC24 MXRA5 STARD8 COL15A1 PDGFRA SHANK3 DACT1 HEG1 NUAK1 ARHGAP29 KIRREL1 MAPK10 CDH6 | 1.65e-05 | 505 | 162 | 13 | M39167 |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 1.70e-05 | 180 | 162 | 8 | M8239 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_3DY_NEGATIVE | RANBP2 ANK3 ATRX GON4L RICTOR RBM39 DNTTIP2 SETD2 NKTR USP47 RGPD5 | 1.71e-05 | 363 | 162 | 11 | M41103 |
| Coexpression | LAKE_ADULT_KIDNEY_C16_COLLECTING_SYSTEM_PRINCIPAL_CELLS_CORTEX | 2.86e-05 | 141 | 162 | 7 | M39235 | |
| Coexpression | GSE4748_LPS_VS_LPS_AND_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_UP | 2.91e-05 | 194 | 162 | 8 | M6493 | |
| Coexpression | PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_UP | 3.02e-05 | 195 | 162 | 8 | M13736 | |
| Coexpression | GSE20727_H2O2_VS_ROS_INHIBITOR_TREATED_DC_DN | 3.49e-05 | 199 | 162 | 8 | M9253 | |
| Coexpression | GSE28726_ACT_CD4_TCELL_VS_ACT_VA24NEG_NKTCELL_DN | 3.62e-05 | 200 | 162 | 8 | M8306 | |
| Coexpression | CARRILLOREIXACH_HEPATOBLASTOMA_VS_NORMAL_UP | TPR COL15A1 RASGRF1 E2F7 KIAA1549 LAMB1 DBN1 HNRNPA1 RTKN2 NUAK1 LMX1B ACAN OSBPL7 UTRN SDK1 DYNC1H1 CREB3L2 | 3.96e-05 | 891 | 162 | 17 | M45033 |
| Coexpression | BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP | NRG1 AHI1 HIVEP1 GON4L RABGAP1 RBM39 SETD2 ATF7IP TLR2 CCSER2 TMF1 ACBD3 PALLD ZC3HAV1 RGPD5 BRWD1 | 5.34e-05 | 822 | 162 | 16 | M6782 |
| Coexpression | SHEN_SMARCA2_TARGETS_UP | RALB ATRX VPS13C RABGAP1 TRIP12 CEP350 NUP133 ARHGAP29 TRMT1L MAPK9 TOR1AIP1 | 7.78e-05 | 429 | 162 | 11 | M29 |
| Coexpression | CUI_TCF21_TARGETS_2_DN | RALB RIPOR2 HIVEP1 STARD8 CEP85L MCF2 RICTOR PTPRC LMX1B ARHGAP29 KIRREL1 PLD1 LRBA PALLD SH3BP5 ZC3HAV1 | 8.35e-05 | 854 | 162 | 16 | M1533 |
| Coexpression | KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_UP | ZCCHC24 TAGAP CAPN2 MIER3 E2F7 DBN1 RBM39 NEK1 PTPRC SSH1 ATAD2B ERRFI1 OSBPL7 UGGT2 UTRN | 1.03e-04 | 778 | 162 | 15 | M17915 |
| Coexpression | ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN | RIPOR2 AHI1 RGPD8 VPS13C MIER3 LAMB1 TIAM2 ADGB CRACD ATF7IP AK5 ERRFI1 KIRREL1 GAPDHS GRAMD1C SDK1 | 1.08e-04 | 873 | 162 | 16 | M16009 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HSERT | RIPOR2 MCF2 SHANK3 AATK LMX1B AK5 CHD5 CYP4X1 UNC79 EPB41L1 SH3BP5 | 1.19e-04 | 450 | 162 | 11 | M39072 |
| Coexpression | LAKE_ADULT_KIDNEY_C17_COLLECTING_SYSTEM_PCS_STRESSED_DISSOC_SUBSET | 1.29e-04 | 240 | 162 | 8 | M39236 | |
| Coexpression | RUTELLA_RESPONSE_TO_HGF_DN | 1.29e-04 | 240 | 162 | 8 | M6413 | |
| Coexpression | CUI_TCF21_TARGETS_2_DN | RALB RIPOR2 HIVEP1 STARD8 CEP85L MCF2 RICTOR PTPRC LMX1B ARHGAP29 KIRREL1 PLD1 LRBA PALLD SH3BP5 ZC3HAV1 | 1.31e-04 | 888 | 162 | 16 | MM1018 |
| Coexpression | BILD_CTNNB1_ONCOGENIC_SIGNATURE | 1.32e-04 | 79 | 162 | 5 | M7102 | |
| Coexpression | MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN | TPR ZNF148 ATRX PDGFRA HNRNPA1L2 HNRNPA1 DACT1 ATF7IP SPHKAP CCSER2 UTRN SH3BP5 | 1.50e-04 | 543 | 162 | 12 | MM997 |
| Coexpression | PEREZ_TP53_TARGETS | ZCCHC24 MXRA5 COL15A1 ANK3 CEP85L VPS13C APC2 KIAA1549 MCF2 RETREG3 KIAA1671 CRACD DACT1 ARID1B HEG1 NUAK1 CREB3L2 ZC3HAV1 BRWD1 | 1.65e-04 | 1201 | 162 | 19 | M4391 |
| Coexpression | DESCARTES_FETAL_THYMUS_VASCULAR_ENDOTHELIAL_CELLS | 1.68e-04 | 131 | 162 | 6 | M40316 | |
| Coexpression | RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN | 1.71e-04 | 250 | 162 | 8 | M13333 | |
| Coexpression | GSE16385_UNTREATED_VS_12H_ROSIGLITAZONE_TREATED_MACROPHAGE_UP | 1.75e-04 | 188 | 162 | 7 | M7940 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | RIPOR2 ANK3 ATRX CEP85L APC2 KIAA1549 MCF2 RICTOR SHANK3 DACT1 AATK NUAK1 CHD5 CYP4X1 UNC79 EPB41L1 SH3BP5 BRWD1 | 1.76e-04 | 1106 | 162 | 18 | M39071 |
| Coexpression | GSE7509_DC_VS_MONOCYTE_WITH_FCGRIIB_STIM_DN | 2.33e-04 | 197 | 162 | 7 | M6835 | |
| Coexpression | GSE44649_WT_VS_MIR155_KO_NAIVE_CD8_TCELL_UP | 2.40e-04 | 198 | 162 | 7 | M9778 | |
| Coexpression | GSE22886_NAIVE_TCELL_VS_NKCELL_DN | 2.40e-04 | 198 | 162 | 7 | M4415 | |
| Coexpression | GSE41978_ID2_KO_AND_BIM_KO_VS_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_DN | 2.47e-04 | 199 | 162 | 7 | M9567 | |
| Coexpression | GSE22935_WT_VS_MYD88_KO_MACROPHAGE_48H_MBOVIS_BCG_STIM_UP | 2.47e-04 | 199 | 162 | 7 | M7766 | |
| Coexpression | GSE360_LOW_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_MAC_DN | 2.47e-04 | 199 | 162 | 7 | M5268 | |
| Coexpression | GSE11924_TFH_VS_TH17_CD4_TCELL_UP | 2.47e-04 | 199 | 162 | 7 | M3156 | |
| Coexpression | LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_LARGE_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_DN | RIPOR2 STARD8 GPR33 CEP85L HDX MUC16 SHANK3 RTKN2 HEG1 ARHGAP29 SH3BP5 | 2.52e-04 | 491 | 162 | 11 | MM455 |
| Coexpression | DURCHDEWALD_SKIN_CARCINOGENESIS_DN | 2.54e-04 | 265 | 162 | 8 | M1684 | |
| Coexpression | GSE9037_WT_VS_IRAK4_KO_BMDM_UP | 2.55e-04 | 200 | 162 | 7 | M5812 | |
| Coexpression | GSE27786_BCELL_VS_MONO_MAC_UP | 2.55e-04 | 200 | 162 | 7 | M4817 | |
| Coexpression | GSE37301_LYMPHOID_PRIMED_MPP_VS_COMMON_LYMPHOID_PROGENITOR_UP | 2.55e-04 | 200 | 162 | 7 | M8853 | |
| Coexpression | GSE17721_LPS_VS_POLYIC_4H_BMDC_UP | 2.55e-04 | 200 | 162 | 7 | M3803 | |
| Coexpression | GSE360_HIGH_VS_LOW_DOSE_B_MALAYI_DC_DN | 2.55e-04 | 200 | 162 | 7 | M5225 | |
| Coexpression | GSE360_L_DONOVANI_VS_T_GONDII_MAC_DN | 2.55e-04 | 200 | 162 | 7 | M5234 | |
| Coexpression | GSE20715_0H_VS_6H_OZONE_LUNG_DN | 2.55e-04 | 200 | 162 | 7 | M4365 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C7_MID_SCHWANN_CELL | 2.74e-04 | 268 | 162 | 8 | M45796 | |
| Coexpression | MASSARWEH_TAMOXIFEN_RESISTANCE_UP | ANK3 PDGFRA RICTOR TACC2 HID1 TBC1D8B NUAK1 UGGT2 PLD1 UTRN CREB3L2 RGPD5 | 2.86e-04 | 583 | 162 | 12 | M17454 |
| Coexpression | CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_DN | 3.02e-04 | 52 | 162 | 4 | M12895 | |
| Coexpression | DURCHDEWALD_SKIN_CARCINOGENESIS_DN | 3.03e-04 | 272 | 162 | 8 | MM1027 | |
| Coexpression | PEREZ_TP53_AND_TP63_TARGETS | 3.14e-04 | 207 | 162 | 7 | M14566 | |
| Coexpression | PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP | 3.53e-04 | 211 | 162 | 7 | M12225 | |
| Coexpression | SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP | 3.58e-04 | 352 | 162 | 9 | M17471 | |
| Coexpression | GSE37605_NOD_VS_C57BL6_IRES_GFP_TREG_DN | 3.88e-04 | 153 | 162 | 6 | M8815 | |
| Coexpression | EIF4E_DN | 3.98e-04 | 100 | 162 | 5 | M2790 | |
| Coexpression | MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN | TPR ZNF148 ATRX PDGFRA HNRNPA1L2 DACT1 ATF7IP SPHKAP CCSER2 UTRN SH3BP5 | 4.02e-04 | 519 | 162 | 11 | M3395 |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | TPR ATRX VPS13C TRIP12 RBM39 CEP350 SETD2 ARID1B PTPRC ATF7IP ATAD2B NKTR UTRN DYNC1H1 | 2.51e-14 | 200 | 163 | 14 | 12f1685ce8f218433068e090c9d839cd5a1910bf |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | RANBP2 CEP85L VPS13C RICTOR RBM39 ARID1B PTPRC ATF7IP NKTR LRBA UTRN DYNC1H1 ZC3HAV1 | 2.54e-13 | 188 | 163 | 13 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | ANK3 ATRX RICTOR RBM39 ARID1B ATF7IP ATAD2B NKTR LRBA UTRN RGPD5 | 2.05e-10 | 199 | 163 | 11 | f0b0097df0026496470a80d8cc9375ffd8389b00 |
| ToppCell | systemic_lupus_erythematosus-flare|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | TPR RIPOR2 ATRX VPS13C RICTOR HNRNPA1 PTPRC ATF7IP NKTR ZC3HAV1 | 3.33e-09 | 198 | 163 | 10 | 4c93ee921d56132d80832d8e94563f32ccf13bbc |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8|bone_marrow / Manually curated celltypes from each tissue | 6.51e-09 | 156 | 163 | 9 | 1545169694f686d28648a68b552c2ae606599d66 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(CH25H+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.00e-08 | 186 | 163 | 9 | 360c3e9e5c3a943e68e6939b4a47821bfc75b553 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.29e-08 | 188 | 163 | 9 | 997dcfc4f08738ab398d8abc15e4fd2fc6619862 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.78e-08 | 191 | 163 | 9 | 1ecd9849d14d5ebf3daf610e83fb50820cafd3ed | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D122|Adult / Lineage, Cell type, age group and donor | 3.95e-08 | 192 | 163 | 9 | 06013a07e3a873b1d1c0451643c528593ac32a9c | |
| ToppCell | LV-10._Endothelium_II|LV / Chamber and Cluster_Paper | 4.32e-08 | 194 | 163 | 9 | b6cc849fa08599bff9839ef382d190cc964e273e | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.32e-08 | 194 | 163 | 9 | 97534c8bba895a7913665e03ae4e5c4a6ad71daf | |
| ToppCell | PBMC_fresh-frozen|World / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.14e-08 | 198 | 163 | 9 | dcc223a0396b8b673e4ed8c6733ec6cd74e9a03a | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.14e-08 | 198 | 163 | 9 | 2e2a4e1756bba6f4fbe529559a97d2993c890b4b | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.69e-07 | 164 | 163 | 8 | 1cb5fbd7050650047ad6f2ca792118e98d58d22b | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 2.33e-07 | 171 | 163 | 8 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.90e-07 | 176 | 163 | 8 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.16e-07 | 178 | 163 | 8 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | Control-Epithelial_cells-AT2|Control / group, cell type (main and fine annotations) | 3.44e-07 | 180 | 163 | 8 | 198b19e7910b4a8cc7e820c525ab357c7f99f578 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L4_RORB_CCDC168|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.44e-07 | 180 | 163 | 8 | a407376209d80177bf7fc4200219030c83cb5f14 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue | 3.59e-07 | 181 | 163 | 8 | f2315414e714ac86211546a935660c4be6e85f1b | |
| ToppCell | COVID-19-Epithelial_cells-AT2|COVID-19 / group, cell type (main and fine annotations) | 4.06e-07 | 184 | 163 | 8 | 369b82f793deab672204558ae4e112cfa5aa9ccc | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-6_LAMP5_CA13_(Lamp5_Lhx6_1)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.41e-07 | 186 | 163 | 8 | 77592a6397b44b2b59a4fc39d7224dd95343efe6 | |
| ToppCell | droplet-Heart-nan-3m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.41e-07 | 186 | 163 | 8 | 0ae5fbe9f210cb25092394267e1d3d6ed05627b8 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 4.41e-07 | 186 | 163 | 8 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | LV-10._Endothelium_II|World / Chamber and Cluster_Paper | 4.59e-07 | 187 | 163 | 8 | 7876dcb4800c2e54874df3d933efb79307a64a97 | |
| ToppCell | Control-Epithelial_cells|Control / group, cell type (main and fine annotations) | 4.78e-07 | 188 | 163 | 8 | 707ebf76cc6fb600b2f07793cf4ea9482c0de79d | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D231|Adult / Lineage, Cell type, age group and donor | 4.98e-07 | 189 | 163 | 8 | dab54a52358f66a8a9460cd6089a06c5fa7e7a5d | |
| ToppCell | RA-10._Endothelium_II|World / Chamber and Cluster_Paper | 4.98e-07 | 189 | 163 | 8 | 75c248b9de5e2fb7a0baa8cdbab516e575cc4394 | |
| ToppCell | COVID-19-lung-AT2|lung / Disease (COVID-19 only), tissue and cell type | 5.39e-07 | 191 | 163 | 8 | 276455a64c2c3503d5048615762eb2ee37f0ac70 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.39e-07 | 191 | 163 | 8 | 7d1595e616f6f111fc2f5bc1b179c5d67d624cc9 | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_2|World / Lineage, Cell type, age group and donor | 5.61e-07 | 192 | 163 | 8 | 58c3737be7acce39fd2b91d70d6d7b2bbaa4f710 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.61e-07 | 192 | 163 | 8 | cc9911e182a289779a2612bc213daae5607689e7 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.84e-07 | 193 | 163 | 8 | fd4d3c0d7caf8a2fff5b3d901fc28d19a8163cdf | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2|Adult / Lineage, Cell type, age group and donor | 5.84e-07 | 193 | 163 | 8 | 738f4f0a9ddde2432b429ab46838e353b1790589 | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 5.84e-07 | 193 | 163 | 8 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.84e-07 | 193 | 163 | 8 | f3cc7cfdbc164a4ed42f87647111522b7d393bcb | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.07e-07 | 194 | 163 | 8 | 7002937e8903e037332a215d00fbc7c7843b33f2 | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 6.81e-07 | 197 | 163 | 8 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | 10x3'2.3-week_17-19-Endothelial-stroma-tip_EC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 6.81e-07 | 197 | 163 | 8 | b212ff28ca2d1fea4140f186ab90941bdca21249 | |
| ToppCell | moderate-Myeloid-Neutrophil|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 7.08e-07 | 198 | 163 | 8 | a6306dac34af5783f3a734ef1eaa7a0c03267b4f | |
| ToppCell | background-Hepatic_Stellate_cells|background / Sample and Cell Type and Tumor Cluster (all cells) | 7.08e-07 | 198 | 163 | 8 | bd11b0e9e80449aab979a02c1023e0638c431c7c | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 7.35e-07 | 199 | 163 | 8 | 8b86c69aaf60feff53aa782559cfece7342a23de | |
| ToppCell | Neuronal-Inhibitory-iA-iA_2(LAMP5)-CA1-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 7.64e-07 | 200 | 163 | 8 | ca5401b76ab014080914bf78042d368cf318effa | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 7.64e-07 | 200 | 163 | 8 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | Neuronal-Inhibitory-iA-iA_2(LAMP5)-CA1--L2-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 7.64e-07 | 200 | 163 | 8 | 70c47d3bbe67d88c5b9dff99c33a603d25fa2ab0 | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_alveolar-AT2|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.64e-07 | 200 | 163 | 8 | b535323e18d9fb0dde1e0026df142c831e48c29f | |
| ToppCell | Neuronal-Inhibitory-iA-iA_2(LAMP5)-CA1|Neuronal / cells hierarchy compared to all cells using T-Statistic | 7.64e-07 | 200 | 163 | 8 | 40286010bd17cf9e34ecd5440953b072ebfae208 | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 7.64e-07 | 200 | 163 | 8 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | COVID-19-COVID-19_Mild|COVID-19 / Disease, condition lineage and cell class | 7.64e-07 | 200 | 163 | 8 | 62c25042086f1afd1102e0720e933c2e476468fd | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 1.20e-06 | 147 | 163 | 7 | 94998bc40f5c08295cfe3bdcbe43f13b1e564b3d | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 2.29e-06 | 162 | 163 | 7 | b4535bcb3f469bc139e73f1122f4070013e5a1de | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.41e-06 | 172 | 163 | 7 | 0c2d0bb767e5ce089b42ad49e8b303a103de2d5c | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.41e-06 | 172 | 163 | 7 | eeed177a03c116e9815a8e086d24efc9643b16a4 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2-Inh_L1-6_PVALB_SCUBE3_(Chandelier_1)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.96e-06 | 176 | 163 | 7 | 95d5a4fdff1b9c715636684d22e06f8727ac0e7a | |
| ToppCell | COVID-19-kidney-Distal_Epi_Doublet_(PCT)|kidney / Disease (COVID-19 only), tissue and cell type | 3.96e-06 | 176 | 163 | 7 | 36f77d878a53b30465b0dea8333a3865dba75613 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma|TCGA-Brain / Sample_Type by Project: Shred V9 | 4.11e-06 | 177 | 163 | 7 | e8ab340b20cd41554c3841fe980e078e878af35f | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-6|TCGA-Ovary / Sample_Type by Project: Shred V9 | 4.27e-06 | 178 | 163 | 7 | 142879e9393e721f9b05a6bb46995c9d6d713c95 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Mucinous_Colon_Adenocarcinoma-10|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 4.43e-06 | 179 | 163 | 7 | cc079ba015326dccde955c5eafa3e4a2e40de192 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.43e-06 | 179 | 163 | 7 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.43e-06 | 179 | 163 | 7 | 3b0f8781232e1d42b6f8913bc989a14b3f978e79 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.77e-06 | 181 | 163 | 7 | 9542c19edc9bd2cba68c01c2a8407705398e3011 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.77e-06 | 181 | 163 | 7 | 8f04f8cac5d705dc5f6cf6f4516d6e45b0aa4ae5 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-5_VIP_TOX2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.94e-06 | 182 | 163 | 7 | 3d7a8d2ee2137b098248597058974ef5ae09c19e | |
| ToppCell | COVID-19-Epithelial_cells-ECM-high_epithelial|COVID-19 / group, cell type (main and fine annotations) | 5.12e-06 | 183 | 163 | 7 | dc1d380bf7564f290256cb7108063d1bd2da732b | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.31e-06 | 184 | 163 | 7 | e2de27cee3ea80f9b7a9a7884ceceeaa67b3214a | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-6_LAMP5_CA13_(Lamp5_Lhx6_1)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.31e-06 | 184 | 163 | 7 | ae0a77e3e520a246b17776bb19503519636b02ee | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.31e-06 | 184 | 163 | 7 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | Control-Epithelial_alveolar-AT_2-Differentiating_AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.50e-06 | 185 | 163 | 7 | 0d2add28ac1f4fa6de7699be009bf8391badaf4c | |
| ToppCell | IPF-Epithelial-ATII|IPF / Disease state, Lineage and Cell class | 5.50e-06 | 185 | 163 | 7 | 563b4e6d92bb5d77a3829556116a8e99aebac615 | |
| ToppCell | IPF-Epithelial-ATII|World / Disease state, Lineage and Cell class | 5.70e-06 | 186 | 163 | 7 | 6a4ff2da0af0f5e590d9f9daa5b5e9ac8c868947 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.70e-06 | 186 | 163 | 7 | 5c4ffe4e4d5536ae9f8794277fe032c693e7dd56 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.70e-06 | 186 | 163 | 7 | f28d72b47624b69a580b4429e2be560a26898591 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal-Granular_Neuron_CB_Gabra6|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.70e-06 | 186 | 163 | 7 | d6c8ce2a32c218dcc63d861cc247152430ed3c8c | |
| ToppCell | Control-Epithelial-ATII|World / Disease state, Lineage and Cell class | 5.70e-06 | 186 | 163 | 7 | f4b6e401e19a71beddc73d8a1e08359f7c4025cf | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.90e-06 | 187 | 163 | 7 | 7b2cd0c618ed081223343f3bec2244c8723c9a31 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.11e-06 | 188 | 163 | 7 | 8268574584e5fb869a6cb8bbd7135cd7454a6a25 | |
| ToppCell | -Unknown-Endothelial-Myofibroblast| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.11e-06 | 188 | 163 | 7 | 6468fa95ad0395395301115286f2d8c0df5d3882 | |
| ToppCell | -Unknown-Endothelial| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.11e-06 | 188 | 163 | 7 | 7a81ac5c79c3eb26639b52d2b9fd5e7ef9798fd6 | |
| ToppCell | -Unknown| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.11e-06 | 188 | 163 | 7 | 9cb718bfe1358c6fd842f096e228eb0abb9aefc6 | |
| ToppCell | 5'-Adult-Appendix-Endothelial-blood_vessel_EC-arterial_capillary|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.11e-06 | 188 | 163 | 7 | a11b12f1857953bcdbfb5f25e127f2350c39567d | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-6_LAMP5_CA13_(Lamp5_Lhx6_1)|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.11e-06 | 188 | 163 | 7 | 3139540a656c0436b2123ea50741ff8d00112165 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.33e-06 | 189 | 163 | 7 | db09d591b885ce2bc9e353f08b6694e2192582e1 | |
| ToppCell | RA-10._Endothelium_II|RA / Chamber and Cluster_Paper | 6.33e-06 | 189 | 163 | 7 | c81787a8c662db5d7814c583dd64562857629e81 | |
| ToppCell | renal_medulla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 6.33e-06 | 189 | 163 | 7 | 830d9cd0dd706bce22eb2416f07b2c31c870a05a | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 6.33e-06 | 189 | 163 | 7 | a48df46274d51e84ffb40264646de7346104efb9 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-6_LAMP5_CA13_(Lamp5_Lhx6_1)|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.55e-06 | 190 | 163 | 7 | 2f54da2bee411f8868348a4c37034184b8f58a89 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.55e-06 | 190 | 163 | 7 | 3b8d1e66ae68c1eee64095e75195d76d97e24026 | |
| ToppCell | Control-Epithelial-ATII|Control / Disease state, Lineage and Cell class | 6.55e-06 | 190 | 163 | 7 | d50902a3abcc18aafa36d83cc2c6e07d7f7cb197 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.55e-06 | 190 | 163 | 7 | 989d4eefd22d66ecb857836f8fdbcf41e3047f84 | |
| ToppCell | COVID-19-lung-AT2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.55e-06 | 190 | 163 | 7 | 27a1a86620fe9b5ee930d388b32352206485e6d0 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.55e-06 | 190 | 163 | 7 | 6c7e1086c0a274cd5527c3104106e372811c9905 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.55e-06 | 190 | 163 | 7 | dc655e4782aab274f0c9b6e36a5ce315e3a1a4b9 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.78e-06 | 191 | 163 | 7 | 3c464645d0e7e423f791bd63bf5bcf11f6b590d3 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.78e-06 | 191 | 163 | 7 | 1c1d13144259b998d4a0e85142f7afef2ef1e63f | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.78e-06 | 191 | 163 | 7 | d9a6f61fcda4f5352488f7f55cb9b57aeacc717f | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.78e-06 | 191 | 163 | 7 | a0332a4ef629510fb313ec119195c44a3f704a80 | |
| ToppCell | 367C-Epithelial_cells|367C / Donor, Lineage, Cell class and subclass (all cells) | 6.78e-06 | 191 | 163 | 7 | d31975fc33779b0b3ff1a50d7c64fec8d08be4d4 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 7.02e-06 | 192 | 163 | 7 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_2-SCMF|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.02e-06 | 192 | 163 | 7 | 67e845e513e76e820f55e2f0d15eb16f2944d05c | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 7.02e-06 | 192 | 163 | 7 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 6.33e-06 | 49 | 102 | 6 | GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_CHROMATIN | |
| Drug | Raloxifene Hydrochloride | ZCCHC24 NRG1 RIPOR2 ANK3 RASGRF1 PDGFRA CAPN2 TACC2 DACT1 HEG1 SAFB AATK SSH1 NUAK1 ATF7IP OSBPL7 ARHGAP29 CDH6 PALLD NUP160 | 3.17e-06 | 857 | 162 | 20 | ctd:D020849 |
| Drug | Clorgyline | 3.37e-06 | 168 | 162 | 9 | ctd:D003010 | |
| Drug | probucol; Up 200; 10uM; MCF7; HG-U133A | ARHGAP32 SBNO2 LMNB1 ACAN ATAD2B CCSER2 DLEC1 SNAPC4 EPB41L1 | 1.18e-05 | 196 | 162 | 9 | 592_UP |
| Drug | Napelline [5008-52-6]; Down 200; 11.2uM; HL60; HT_HG-U133A | 1.22e-05 | 197 | 162 | 9 | 2522_DN | |
| Drug | 2-propylpentanoic acid; Down 200; 1000uM; HL60; HG-U133A | 1.38e-05 | 200 | 162 | 9 | 409_DN | |
| Drug | testosterone enanthate | TPR RANBP2 PDE4A MXRA5 ZNF148 ANK3 ATRX CAPN2 RETREG3 NEK1 TMF1 NKTR ACBD3 PALLD USP47 | 1.62e-05 | 575 | 162 | 15 | ctd:C004648 |
| Drug | Etifenin [63245-28-3]; Down 200; 12.4uM; PC3; HT_HG-U133A | 4.23e-05 | 178 | 162 | 8 | 3998_DN | |
| Drug | Kinome_3024 | 5.03e-05 | 2 | 162 | 2 | CID011539329 | |
| Drug | Kinome_3019 | 5.03e-05 | 2 | 162 | 2 | CID011658882 | |
| Drug | Kinome_3025 | 5.03e-05 | 2 | 162 | 2 | CID011715520 | |
| Drug | Kinome_3027 | 5.03e-05 | 2 | 162 | 2 | CID011640926 | |
| Drug | Kinome_3028 | 5.03e-05 | 2 | 162 | 2 | CID011590363 | |
| Drug | trapidil | 5.32e-05 | 57 | 162 | 5 | CID000005531 | |
| Drug | Fluoxetine hydrochloride [59333-67-4]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 5.35e-05 | 184 | 162 | 8 | 5356_UP | |
| Drug | Colchicine [64-86-8]; Up 200; 10uM; MCF7; HT_HG-U133A | 6.46e-05 | 189 | 162 | 8 | 5675_UP | |
| Drug | Fenbufen [36330-85-5]; Down 200; 15.8uM; PC3; HT_HG-U133A | 6.96e-05 | 191 | 162 | 8 | 4279_DN | |
| Drug | Norgestrel-(-)-D [797-63-7]; Down 200; 12.8uM; PC3; HT_HG-U133A | 6.96e-05 | 191 | 162 | 8 | 4269_DN | |
| Drug | vanadyl | PDE4A PDGFRA OMG PTPRC PTPRZ1 PLD1 LRBA MAPK9 MAPK10 DYNC1H1 | 7.30e-05 | 307 | 162 | 10 | CID000061671 |
| Drug | Melatonin [73-31-4]; Down 200; 17.2uM; MCF7; HT_HG-U133A | 7.48e-05 | 193 | 162 | 8 | 3293_DN | |
| Drug | PHA-00745360 [351320-33-7]; Down 200; 10uM; PC3; HT_HG-U133A | 7.76e-05 | 194 | 162 | 8 | 4559_DN | |
| Drug | Phensuximide [86-34-0]; Up 200; 21.2uM; PC3; HT_HG-U133A | 8.33e-05 | 196 | 162 | 8 | 5097_UP | |
| Drug | Miconazole [22916-47-8]; Down 200; 9.6uM; PC3; HT_HG-U133A | 8.33e-05 | 196 | 162 | 8 | 6615_DN | |
| Drug | Scoulerine [6451-73-6]; Up 200; 12.2uM; PC3; HT_HG-U133A | 8.33e-05 | 196 | 162 | 8 | 5111_UP | |
| Drug | Benzthiazide [91-33-8]; Down 200; 9.2uM; PC3; HT_HG-U133A | 8.64e-05 | 197 | 162 | 8 | 6607_DN | |
| Drug | sodium 4-phenylbutyrate; Down 200; 1000uM; MCF7; HG-U133A | 8.95e-05 | 198 | 162 | 8 | 407_DN | |
| Drug | (+/-)-thalidomide; Down 200; 100uM; MCF7; HG-U133A | 8.95e-05 | 198 | 162 | 8 | 266_DN | |
| Drug | Phentolamine hydrochloride [73-05-2]; Down 200; 12.6uM; HL60; HT_HG-U133A | 8.95e-05 | 198 | 162 | 8 | 2362_DN | |
| Drug | PF-00562151-00 [351320-12-2]; Up 200; 10uM; PC3; HT_HG-U133A | 8.95e-05 | 198 | 162 | 8 | 6907_UP | |
| Drug | Sulfathiazole [72-14-0]; Up 200; 15.6uM; HL60; HG-U133A | 8.95e-05 | 198 | 162 | 8 | 1963_UP | |
| Drug | Alprenolol hydrochloride [13707-88-5]; Up 200; 14uM; PC3; HT_HG-U133A | 9.26e-05 | 199 | 162 | 8 | 7141_UP | |
| Drug | 2-phenylindole | 9.60e-05 | 13 | 162 | 3 | CID000013698 | |
| Disease | myopathy (implicated_via_orthology) | 5.02e-06 | 48 | 153 | 5 | DOID:423 (implicated_via_orthology) | |
| Disease | body weight | NRG1 HIVEP1 RASGRF1 VPS13C HDX RGPD1 E2F7 GON4L RABGAP1 TRIP12 SBNO2 MFAP3 SETD2 FASN AATK LMX1B ACAN SPHKAP UNC79 NUP160 | 8.84e-06 | 1261 | 153 | 20 | EFO_0004338 |
| Disease | diastolic blood pressure, systolic blood pressure | NRG1 RIPOR2 BRIP1 ANK3 MIER3 CEP350 KIAA1671 RTKN2 ARID1B ACAN DLEC1 PLD1 SH3BP5 CREB3L2 | 1.12e-05 | 670 | 153 | 14 | EFO_0006335, EFO_0006336 |
| Disease | Malignant neoplasm of breast | NRG1 BRIP1 STARD8 CEP85L APC2 TACC2 DBN1 SETD2 FASN ARID1B PTPRC CHD5 NUP133 ARHGAP29 DLEC1 LRBA TOR1AIP1 | 4.49e-05 | 1074 | 153 | 17 | C0006142 |
| Disease | pancreatic adenocarcinoma (is_implicated_in) | 5.94e-05 | 15 | 153 | 3 | DOID:4074 (is_implicated_in) | |
| Disease | Alzheimer's disease (is_marker_for) | 6.19e-05 | 257 | 153 | 8 | DOID:10652 (is_marker_for) | |
| Disease | keratoconjunctivitis (is_marker_for) | 7.99e-05 | 3 | 153 | 2 | DOID:9368 (is_marker_for) | |
| Disease | body surface area | ZCCHC24 HIVEP1 RGPD1 E2F7 TRIP12 TIAM2 MFAP3 AATK ACAN DLEC1 MAPK9 UNC79 | 1.40e-04 | 643 | 153 | 12 | EFO_0022196 |
| Disease | Sotos' syndrome | 1.59e-04 | 4 | 153 | 2 | C0175695 | |
| Disease | Schizophrenia | NRG1 ARHGAP32 PDE4A AHI1 ANK3 DBN1 SHANK3 SBNO2 RTKN2 LMX1B PTPRZ1 TLR2 MAGEC1 NRG3 | 2.14e-04 | 883 | 153 | 14 | C0036341 |
| Disease | hereditary spastic paraplegia 76 (implicated_via_orthology) | 2.64e-04 | 5 | 153 | 2 | DOID:0110821 (implicated_via_orthology) | |
| Disease | DiGeorge syndrome (is_implicated_in) | 2.64e-04 | 5 | 153 | 2 | DOID:11198 (is_implicated_in) | |
| Disease | response to iloperidone | 3.95e-04 | 6 | 153 | 2 | GO_0036287 | |
| Disease | congenital muscular dystrophy (implicated_via_orthology) | 3.95e-04 | 6 | 153 | 2 | DOID:0050557 (implicated_via_orthology) | |
| Disease | NEPHROTIC SYNDROME, STEROID-RESISTANT, AUTOSOMAL RECESSIVE | 5.01e-04 | 30 | 153 | 3 | C1868672 | |
| Disease | Intellectual Disability | 5.66e-04 | 447 | 153 | 9 | C3714756 | |
| Disease | intellectual disability (implicated_via_orthology) | 6.35e-04 | 75 | 153 | 4 | DOID:1059 (implicated_via_orthology) | |
| Disease | Adenocarcinoma of lung (disorder) | 7.42e-04 | 206 | 153 | 6 | C0152013 | |
| Disease | Abnormality of refraction | ARHGAP32 BRIP1 ANK3 PHF19 RASGRF1 ADAMTS9 KIRREL1 DLEC1 UTRN TOR1AIP1 CREB3L2 | 8.04e-04 | 673 | 153 | 11 | HP_0000539 |
| Disease | Profound Mental Retardation | 8.08e-04 | 139 | 153 | 5 | C0020796 | |
| Disease | Vertigo | 8.08e-04 | 139 | 153 | 5 | HP_0002321 | |
| Disease | Mental Retardation, Psychosocial | 8.08e-04 | 139 | 153 | 5 | C0025363 | |
| Disease | Mental deficiency | 8.08e-04 | 139 | 153 | 5 | C0917816 | |
| Disease | Duchenne muscular dystrophy (implicated_via_orthology) | 8.61e-04 | 36 | 153 | 3 | DOID:11723 (implicated_via_orthology) | |
| Disease | age at onset, coronary stenosis | 9.39e-04 | 9 | 153 | 2 | EFO_0004847, MONDO_0006715 | |
| Disease | vein graft stenosis | 9.39e-04 | 9 | 153 | 2 | EFO_0007051 | |
| Disease | mean reticulocyte volume | RIPOR2 BRIP1 HNRNPA1 SBNO2 CEP350 KAT7 SAFB PTPRC ATF7IP AK5 ATAD2B CDH6 | 9.74e-04 | 799 | 153 | 12 | EFO_0010701 |
| Disease | neurodegenerative disease (implicated_via_orthology) | 9.77e-04 | 145 | 153 | 5 | DOID:1289 (implicated_via_orthology) | |
| Disease | dry eye syndrome (is_marker_for) | 1.17e-03 | 10 | 153 | 2 | DOID:10140 (is_marker_for) | |
| Disease | childhood aggressive behaviour measurement | 1.21e-03 | 89 | 153 | 4 | EFO_0007663 | |
| Disease | visual epilepsy (biomarker_via_orthology) | 1.26e-03 | 90 | 153 | 4 | DOID:11832 (biomarker_via_orthology) | |
| Disease | Neurodevelopmental Disorders | 1.42e-03 | 93 | 153 | 4 | C1535926 | |
| Disease | nucleus accumbens volume change measurement | 1.42e-03 | 11 | 153 | 2 | EFO_0021493 | |
| Disease | Cleft palate, tobacco smoke exposure measurement, cleft lip, parental genotype effect measurement | 1.42e-03 | 11 | 153 | 2 | EFO_0003959, EFO_0005939, EFO_0009115, HP_0000175 | |
| Disease | selective IgA deficiency disease | 1.76e-03 | 46 | 153 | 3 | EFO_1001929 | |
| Disease | Neuroblastoma | 1.88e-03 | 47 | 153 | 3 | C0027819 | |
| Disease | asthma | AHI1 HIVEP1 COL15A1 E2F7 MUC16 TIAM2 SBNO2 PTPRC ADAMTS9 OSBPL7 UNC79 | 1.92e-03 | 751 | 153 | 11 | MONDO_0004979 |
| Disease | alcohol and nicotine codependence | 2.01e-03 | 13 | 153 | 2 | EFO_0004776 | |
| Disease | fatty acid measurement, fetal genotype effect measurement, breast milk measurement | 2.01e-03 | 13 | 153 | 2 | EFO_0005110, EFO_0007959, EFO_0009092 | |
| Disease | Cardiotoxicity | 2.01e-03 | 13 | 153 | 2 | C0876994 | |
| Disease | Fetal Alcohol Spectrum Disorders | 2.01e-03 | 13 | 153 | 2 | C2985290 | |
| Disease | QRS-T angle | 2.29e-03 | 106 | 153 | 4 | EFO_0020097 | |
| Disease | Pneumoconiosis | 2.33e-03 | 14 | 153 | 2 | C0032273 | |
| Disease | Bagassosis | 2.33e-03 | 14 | 153 | 2 | C0004681 | |
| Disease | fatty acid measurement, breast milk measurement, parental genotype effect measurement | 2.33e-03 | 14 | 153 | 2 | EFO_0005110, EFO_0005939, EFO_0009092 | |
| Disease | pulse pressure measurement | NRG1 MXRA5 COL15A1 TRHR PHF19 PDGFRA RABGAP1 FASN ARID1B ATAD2B OSBPL7 DCLRE1A DLEC1 PALLD NUP160 CREB3L2 | 2.43e-03 | 1392 | 153 | 16 | EFO_0005763 |
| Disease | Congestive heart failure | 2.62e-03 | 110 | 153 | 4 | C0018802 | |
| Disease | Heart failure | 2.62e-03 | 110 | 153 | 4 | C0018801 | |
| Disease | Left-Sided Heart Failure | 2.62e-03 | 110 | 153 | 4 | C0023212 | |
| Disease | Heart Failure, Right-Sided | 2.62e-03 | 110 | 153 | 4 | C0235527 | |
| Disease | Heart Decompensation | 2.62e-03 | 110 | 153 | 4 | C1961112 | |
| Disease | Myocardial Failure | 2.62e-03 | 110 | 153 | 4 | C1959583 | |
| Disease | glycerol-3-phosphate measurement | 2.68e-03 | 15 | 153 | 2 | EFO_0010488 | |
| Disease | Glioblastoma Multiforme | 2.71e-03 | 111 | 153 | 4 | C1621958 | |
| Disease | aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement | 2.99e-03 | 364 | 153 | 7 | EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946 | |
| Disease | lung small cell carcinoma (is_marker_for) | 3.06e-03 | 16 | 153 | 2 | DOID:5409 (is_marker_for) | |
| Disease | Fetal Alcohol Syndrome | 3.45e-03 | 17 | 153 | 2 | C0015923 | |
| Disease | colorectal cancer (is_implicated_in) | 3.69e-03 | 121 | 153 | 4 | DOID:9256 (is_implicated_in) | |
| Disease | visceral adipose tissue measurement | 3.73e-03 | 481 | 153 | 8 | EFO_0004765 | |
| Disease | Schizophrenia | 3.87e-03 | 18 | 153 | 2 | cv:C0036341 | |
| Disease | body fat percentage | 4.06e-03 | 488 | 153 | 8 | EFO_0007800 | |
| Disease | MYELODYSPLASTIC SYNDROME | 5.14e-03 | 67 | 153 | 3 | C3463824 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SFTSESISRVSETES | 241 | Q8IYS0 | |
| REESDFDSASIHSAS | 296 | Q8TDI0 | |
| VSEDDSETQSVSSFS | 311 | O60239 | |
| ESSVRSVSSDSHQDD | 266 | Q8N157 | |
| TTDEAAHLFSSNETI | 641 | Q8IZF6 | |
| SDLPSVSETDETATH | 541 | Q8N7X0 | |
| VSETDETATHSQTDL | 546 | Q8N7X0 | |
| ISDVSDLEETTTLAS | 281 | Q13790 | |
| ALFESTFSEDSSVER | 316 | Q49SQ1 | |
| SSTISVHDPFSDVSD | 1301 | Q8NFD5 | |
| SIDVSSAAEAEAITS | 241 | A6NHC0 | |
| TLHIVDSSESVSEDD | 211 | Q9Y4B4 | |
| LSFETTDESLRSHFE | 21 | Q32P51 | |
| LVFSITEHESFTATA | 91 | P11234 | |
| EDALDDSVSSSSVHA | 2231 | P49792 | |
| VTERTDASSASSFLD | 326 | Q14498 | |
| DALDDSVSSSSVHAS | 1256 | Q99666 | |
| DVADAASEVEVSSTS | 1511 | Q99666 | |
| DALDDSVSSSSVHAS | 1256 | O14715 | |
| DVADAASEVEVSSTS | 1511 | O14715 | |
| STAFSESLAAEISSV | 701 | O75154 | |
| EHIVEREAETSFSTS | 321 | Q02297 | |
| SLEFVEASTVSLTDS | 726 | Q9HCM3 | |
| EASTVSLTDSEAHFT | 731 | Q9HCM3 | |
| SLTDSEAHFTSAFIE | 736 | Q9HCM3 | |
| LASVETEDSASENTA | 676 | P56975 | |
| EESAIETGSSSSTFI | 1046 | P16234 | |
| SVSSDSVSTLNSEDF | 11 | Q9Y3P9 | |
| TEQTLASDTDSSLDA | 401 | P45984 | |
| STHLFTSGEETEETS | 856 | Q8WXI7 | |
| TESNTVFSSVSLDAA | 6091 | Q8WXI7 | |
| SSTSHEILTTDEDTT | 6861 | Q8WXI7 | |
| ELDTVSSTATSHGAD | 10621 | Q8WXI7 | |
| VDELFSSHSDLDSDS | 541 | Q8WUM0 | |
| SESSDSEVHSEASPT | 2181 | Q5D862 | |
| SSTSSLEAEVDFTVI | 611 | Q9H4G0 | |
| EDSDFSTDLEHTDSS | 16 | O95251 | |
| HASLEPDDTSFSVSS | 666 | Q7Z353 | |
| SSDTLLESDSLTDSE | 881 | O60732 | |
| AIIDTTDDSTATESA | 1116 | O60732 | |
| STSVDHSSTDLESTD | 1596 | Q9BY89 | |
| TDQTLASDTDSSLEA | 441 | P53779 | |
| DELTLDTSFSTTERH | 771 | Q96PY6 | |
| DTSFSTTERHTVGEV | 776 | Q96PY6 | |
| IHQFSIESDTDLSET | 101 | Q9Y6K8 | |
| AIHSSDTTSSDEERF | 331 | Q9ULI0 | |
| HDGTESSEDSFSFTV | 1606 | Q5SZK8 | |
| VEESEASSSVSISHS | 421 | P20700 | |
| AATEASSDIDIATSE | 31 | P0C7V8 | |
| VASSEGSEELFSSVS | 76 | Q6PEV8 | |
| FSSREEFVVAVSHSS | 796 | P27815 | |
| AAFSTLTTASVEESE | 1581 | P50851 | |
| STLEESTFHSVNTLE | 331 | P0C6S8 | |
| LLTSIESETAASEET | 1626 | P07942 | |
| FNLHSLSSESEDETE | 1301 | Q8IWU2 | |
| TAVSVHVSESSDDDE | 441 | Q9H3P7 | |
| DTIETDTATADTTVA | 451 | Q16643 | |
| SVVLDTDAEFVSDSS | 646 | Q9ULI3 | |
| DLTPSVTSHETSDFF | 126 | Q7Z3K6 | |
| STTHAASETLEFGSE | 881 | P23471 | |
| HSFVTASSTSVDDAL | 1441 | A7KAX9 | |
| IHSDASLFLESTEDT | 1496 | Q6R327 | |
| LTASDDSSSIFEEET | 326 | Q8IVE3 | |
| SSFELSASSHSDDDV | 46 | P55082 | |
| EETHTVETATSPTDA | 2246 | P16112 | |
| HSTFESALESLAEFS | 871 | Q9BX63 | |
| SAEVFIEGASSTDSD | 356 | Q8WX93 | |
| TSSEDTLTVVTADHS | 366 | P05186 | |
| SFENVSVESVDSSSE | 171 | Q52LW3 | |
| EDALDDSVSSSSVHA | 1256 | A6NKT7 | |
| SDDVDDISLSSLSSS | 391 | Q9H7U1 | |
| ISALHTSSDDSFSLS | 861 | O95996 | |
| FLAHSSEESEETSSP | 21 | P46100 | |
| SEDSGLSTAFTIAHE | 421 | Q9P2N4 | |
| ESLFHSTVVDTSEDE | 731 | Q9NYF0 | |
| FSSSDEELVDVSASV | 371 | Q96AV8 | |
| DSEGEVTSALSATFS | 141 | Q7Z5L3 | |
| TTSISDLEFSSDFTL | 426 | O60678 | |
| VAHTEFTTSSDSETA | 811 | Q6ZU35 | |
| ESGSSFSDIDVHSEV | 296 | Q8N118 | |
| FRHSSATESADSIEI | 956 | O95886 | |
| EESLLESDVESTASS | 386 | Q3T8J9 | |
| TLDTDSTLEDLSGHS | 1226 | Q5VT06 | |
| SIATTAEFSHDTDAT | 3396 | Q12955 | |
| SAEETENDHSTETLT | 756 | Q5SZL2 | |
| TLSESEVEDSLATSL | 1526 | Q9NSI6 | |
| SDELTSESTFDRTFE | 276 | Q6VMQ6 | |
| AFISTEETELEHTST | 846 | P10911 | |
| DVESSSSSSSREEHA | 326 | Q6ZW76 | |
| HSVDTASTSDAVTFI | 1156 | Q14204 | |
| HSDREDDTASVSTAT | 551 | Q96J84 | |
| VADSLSSLESVTTDA | 746 | P55285 | |
| ALSSELESSSFVDSD | 181 | O14640 | |
| SLSDLEFDASTLHES | 606 | Q6PJP8 | |
| SFEETTSQIDDSFST | 1431 | Q9Y4K1 | |
| VVSTHSSTLDEEVSE | 1076 | Q49AJ0 | |
| ALSSELESSSFVDSD | 181 | P54792 | |
| FVDSDEDDSTSRLSS | 191 | P54792 | |
| TDESTFDDIVHSFVS | 541 | P49327 | |
| DEVVSTDFLGDTHSS | 351 | O14556 | |
| SIDITSAADSEAITF | 241 | P17655 | |
| EDSLTTAAAATEVSL | 456 | P39059 | |
| TAAAATEVSLSTFED | 461 | P39059 | |
| EFSHETDSSVEGSSS | 1346 | Q9Y238 | |
| DSDFSSETEAVTTLQ | 1561 | Q7Z5N4 | |
| THITTSDSFNDDEVE | 96 | Q70SY1 | |
| SSADDLTPSVTSHEA | 141 | Q8N344 | |
| SLTTAESESFVLDFS | 101 | Q86XI6 | |
| TSILSLADSHTEFFD | 391 | Q9BZF2 | |
| DVADAASEVEVSSTS | 1496 | P0DJD0 | |
| VLSATDIDSEDSTIH | 566 | P0C091 | |
| DGSETTEDSFSLTVT | 1611 | P0C091 | |
| TEDSFSLTVTDGTHT | 1616 | P0C091 | |
| LETETSSTHSESSVV | 161 | Q8TC99 | |
| LAHTTLTLESAEDSF | 236 | Q8IZC4 | |
| ESFTEDSEDTVSIRS | 331 | Q8TDW5 | |
| FLTDSSSTTGSVEDE | 3211 | P46939 | |
| EDALDDSVSSSSVHA | 1256 | Q7Z3J3 | |
| SLSSIEEDFLTASEH | 206 | Q2M3C7 | |
| SESHVQSASEDTVTE | 701 | Q7Z2T5 | |
| DHFSTELDDITVTDT | 361 | P34981 | |
| SITSDDSLEHTDSSD | 286 | Q8N103 | |
| DSLEHTDSSDVSTLQ | 291 | Q8N103 | |
| EDTAEATSGIFTDTS | 861 | Q6ZMQ8 | |
| SSSESSSESELEHER | 206 | P30414 | |
| LHDADSISSIDSTSS | 571 | Q13393 | |
| VLSTDTDSISAEDSD | 1101 | Q8IZX4 | |
| VLSSTEVLSTDTDSS | 1076 | P21675 | |
| FEEATTASIATTLSS | 516 | O60331 | |
| DESHSFTLTSETNTA | 531 | O15197 | |
| STVDSAEDVHSLDSC | 166 | Q8IV36 | |
| TLDHDSASSASPTVD | 291 | Q8IV36 | |
| IFSSSVDSLSDIVDT | 106 | Q9Y2G9 | |
| VISDDSVLSSDSFDL | 571 | O60285 | |
| GAVSEDSILSSESFD | 541 | Q9H093 | |
| TSQETLIDFALTSTD | 391 | Q12769 | |
| ITHDDVSSIFLNSET | 281 | Q13972 | |
| SSDTDFLLEDSTLSD | 176 | Q9UJM3 | |
| EDTSTETINSHEAAA | 336 | P23515 | |
| EEGHSISDTVASSSE | 436 | Q92502 | |
| SSLSLTVESALESFD | 651 | Q9Y4F9 | |
| SSAASELAEASSEEL | 321 | Q15424 | |
| TFSTEDLSSEADPST | 986 | Q8WYL5 | |
| VADSQDTTLSESSFL | 1001 | Q8WYL5 | |
| EDTQTTLEDFSRTAS | 721 | Q14CN2 | |
| ATSSSDTETTEVHAL | 861 | P51788 | |
| SEEVSSTVHIETFTT | 66 | Q5T681 | |
| ATDITADSSSEFSEE | 176 | Q6ZUT1 | |
| AITDSEHSDAEVSCT | 281 | Q86VR2 | |
| QESHTEAISDAETSS | 176 | Q5QJE6 | |
| EAISDAETSSSDISF | 181 | Q5QJE6 | |
| EAEARSSFSDSSEES | 1806 | O15417 | |
| SGTSTTSDIEVLDHE | 251 | P82094 | |
| LESSASVFSENTEET | 231 | A4D1E1 | |
| EEDDQDSSHSSVTTV | 221 | Q5JTV8 | |
| IETSTETAESSSESL | 476 | Q8IVF5 | |
| ETAESSSESLSSLEQ | 481 | Q8IVF5 | |
| SSSSSTEGEEDLFVS | 266 | Q6ZNA4 | |
| SSESGELTDTHTSFA | 1386 | Q9BYB0 | |
| HDISTELAISSESTE | 396 | Q0IIM8 | |
| IRDEEVSSADISSSS | 516 | P12270 | |
| SVDSDILSSSHSSDT | 956 | Q96K76 | |
| SDTVSLSDSDSDLSL | 26 | Q9Y5U2 | |
| TFESISEDDSSLSHL | 521 | Q5T6S3 | |
| FSSDSTEVTTVDLSV | 2741 | Q709C8 | |
| SSDSEEAFETPESTT | 1946 | O95359 | |
| EAASPLEDSSSSTVH | 231 | Q9ULM0 | |
| LEDSSSSTVHSGETV | 236 | Q9ULM0 | |
| HTSDDSEVVFSSCDL | 991 | Q9BYW2 | |
| SGSHVEISESSLESD | 26 | Q5SXM2 | |
| VTSTTSSRVDDHDSE | 496 | Q7Z2W4 | |
| HEISFSVADTEVTSS | 556 | Q9UQR1 | |
| LISTSVTADVEDFST | 696 | Q9NYU1 | |
| LSFETTDESLRSHFE | 21 | P09651 | |
| SIVSESDVSSFEIQH | 1146 | Q14669 | |
| DTDLDTFHFSELSTG | 231 | O60603 | |
| STFERENDFSETTTS | 61 | P08575 | |
| LAEIEHSSTESSFDS | 1286 | P15822 | |
| SLSHTSSFSASLDIE | 1311 | P15822 | |
| HSILSTSDSDSLVFE | 1621 | Q9P2D8 | |
| TFTDLSAAEASSEEV | 56 | Q6UXV3 | |
| SSLTEHFSDLTLTSE | 106 | Q8N2G6 | |
| EDSTTSGLTEESTAF | 1346 | Q9UKN1 | |
| FTEDSTTSGLTEEST | 2901 | Q9UKN1 | |
| EDSTTSGLTEESTAF | 3986 | Q9UKN1 | |
| FHDIDSDTSLTSLSD | 356 | O60663 | |
| DSSTSQLFEDSTIGE | 1011 | Q9NR99 |